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ABSTRACT 
GESTATIONAL WEIGHT GAIN, OFFSPRING ASTHMA AND WHEEZE 
PHENOTYPES IN PROJECT VIVA 
MAY 2019 
KATHRYN A. WAGNER, B.A., UNIVERSITY OF MASSACHUSETTS AMHERST 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Youssef Oulhote 
In the US, 8.4% of children are diagnosed with asthma by age 18, making asthma 
one of the most common chronic conditions among children. Additionally, 25% of 
children experience persistent wheezing by age 6, an indicator of childhood asthma. Both 
childhood asthma and persistent wheezing may be linked to inflammatory and immune 
mechanisms, which are associated with inadequate and excessive gestational weight gain. 
Studies investigating the relationship between gestational weight gain and offspring 
asthma and wheeze phenotypes are limited by self-reported gestational weight gain, early 
age at asthma and wheeze assessments, limited adjustment for potential confounders and 
no trimester-specific evaluations. Therefore, we investigated the association between 
total and trimester-specific gestational weight gain, offspring asthma and wheeze 
phenotypes among 2128 mother-child pairs in Project Viva, a prospective cohort study in 
eastern Massachusetts. Gestational weight gain was abstracted from medical records and 
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self-reported prepregnancy weight, and defined both continuously and using Institute of 
Medicine guidelines. Offspring asthma was obtained via maternal report at approximately 
7 years, while wheeze trajectories were derived via latent class mixed models based on 
presence of wheeze between 1 and 9 years, inclusively, via maternal report. We 
investigated the relationship between gestational weight gain, offspring asthma and 
wheeze phenotypes using multivariable regressions and predicted probabilities, adjusting 
for important covariates. Most women had excessive gestational weight gain (56%), 
while 31% had adequate gestational weight gain and 13% had inadequate gestational 
weight gain. Approximately 18% of children had current mid-childhood asthma, 13% had 
early transient wheeze and 13% had persistent wheeze. We found a non-linear association 
between total gestational weight gain and offspring current mid-childhood asthma. 
Additionally, there was a 36% decreased odds of early transient wheeze among children 
of mothers with excessive third trimester gestational weight gain (aOR= 0.64; 95% CI: 
0.42-0.98). This study adds to the body of literature by incorporating adequate inclusion 
of confounders and risk factors for adjustment, as well as being the first study to evaluate 
the association between trimester-specific gestational weight gain, offspring asthma and 
wheeze phenotypes.  
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CHAPTER I 
BACKGROUND AND SIGNIFICANCE 
 
A. Introduction 
Asthma is a chronic lung disease that causes inflammation and narrowing of the 
airways.1 This causes recurrent wheezing, chest tightness and discomfort, coughing, 
shortness of breath, reduced energy and feelings of weakness or tiredness.1,2 Asthma is 
usually diagnosed in childhood (<18 years) and is one of the most common chronic 
conditions among children.3,4 In the United States, approximately 6.2 million children 
under the age of 18, or 8.4%, have been diagnosed with asthma, with boys having higher 
prevalence of childhood asthma than girls.5,28,29,30 Overall rates have been fairly 
consistent over the past two decades;4,5 therefore assessing potential modifiable risk 
factors for childhood asthma remains critical.   
Childhood asthma has serious, long-term health consequences that can last a lifetime. 
The mucus that accumulates in the lungs due to asthmatic symptoms increases the 
likelihood of developing bronchitis and pneumonia.6 These conditions can further affect 
the lungs by causing permanent lung scarring or damage and, in the case of pneumonia, 
can lead to antibiotic resistance if repeat infections occur.6 Additionally, if asthma 
symptoms are not well controlled, chronic inflammation of the airways can lead to lung 
scarring and have health effects similar to chronic obstructive pulmonary disease, or 
COPD.6 Uncontrolled and untreated asthma is particularly harmful and can be fatal; in 
2015, 3,615 people in the United States, or 10 people per day, died from asthma.6,7  
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In addition to lung health consequences, childhood asthma can cause lifestyle changes 
that affect long-term health. Children who have asthma are more likely to miss school 
than those who do not have asthma, and later in life this could also lead to missed work.8 
Additionally, asthma is the third leading cause of hospitalization in children.8 Asthma 
also causes changes to an individual’s daily lifestyle and personal choices, which can 
have repercussions on personal health. Asthma, particularly exercise-induced asthma, can 
cause children to develop a decreased exercise tolerance, which can lead to a sedentary 
lifestyle and associated negative health effects including obesity, diabetes, and high blood 
pressure.3,6 Sleep can also be affected by asthma since coughing, wheezing and shortness 
of breath can all make it difficult to fall asleep and/or stay asleep.3,9  
Established risk factors for developing childhood asthma include allergies, eczema, 
family history of allergies, eczema and/or asthma, frequent respiratory infections, low 
birth weight, second-hand smoke before and/or after birth and growing up in a low-
income, urban environment.1,2,4,5 African-Americans and Puerto Ricans are at an 
increased risk for asthma than those of other racial and ethnic groups.1,4,5 Additionally, 
boys have childhood asthma at a higher prevalence than girls, though this pattern 
switches after puberty.28,29,30 It is important to continue to explore potential modifiable 
risk factors for childhood asthma due to its large, continued prevalence in children and its 
serious health and personal consequences.  
Wheezing during childhood is a common ailment, characterized by a high-pitched 
whistling sound made while breathing, particularly exhaling, caused by narrowed airways 
or inflammation.31 While wheezing is commonly associated with asthma, it is also a 
symptom of multiple other respiratory and immunologic conditions, such as respiratory 
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infections, allergies and cystic fibrosis.31, 32,33 Wheezing is most often diagnosed within 
the first six years of life.31  The Global Initiative for Asthma (GINA) has produced 
guidelines, proposing a number of tools, including frequency, gravity and duration of 
wheezing symptoms, to guide clinicians in determining whether a child’s wheezing 
patterns are indicative of asthma.31 One system for wheeze classification is the time-
trend, or temporal, classification which categorizes wheezing into early transient (ending 
before 3 years), recurrent or persistent (starting before 3 years and persisting beyond 6 
years) and late onset wheeze (starting after 3 years).35 It is estimated that by age 6, 20-
30% of children have recurrent or persistent wheezing and half experience at least one 
episode of wheezing of any kind.31,33 Children with recurrent and persistent episodes of 
wheeze have been determined by the GINA guidelines to have a higher probability of 
having asthma, while early transient wheeze is more indicative of having early 
respiratory infections.31,43 Properly identifying when wheezing symptoms represent 
asthma is imperative for clinicians since early identification of asthma may predict long-
term outcomes and improved treatment responses.31, 35 
Childhood wheezing, though a symptom of multiple respiratory and immunologic 
conditions, has been associated with negative health consequences in and of itself. 
Childhood wheezing has been shown to decrease adulthood lung function as compared to 
children with no wheezing in a recent meta-analysis.34  Additionally, childhood atopic 
wheezing was found to be significantly associated with chronic obstructive pulmonary 
disease (COPD) prevalence in adults in the same meta-analysis.34 
In addition to health consequences, wheezing of any phenotype can be severe and 
result in reduced quality of life stemming from frequent use of health care systems, 
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leading to increased economic costs.31,36 Many of the health and social consequences 
associated with asthma, such as sleep disturbances, limited activities, and missed school 
are also applicable to childhood wheezing due to the frequent relationship between the 
two.  
Established risk factors associated with childhood wheezing include exposure to 
environmental tobacco smoke, maternal smoking during pregnancy, breast feeding for 
less than or equal to six months, having siblings, attending a day care center, personal 
history of eczema or allergic rhinitis, having acid reflux, low socioeconomic status, 
crowding, and allergen exposure. 37, 32, 38 Males are also more likely to experience 
wheezing in childhood as compared to females.37,38,41 It is important to continue to 
explore potential modifiable risk factors for childhood wheeze, particularly recurrent or 
persistent wheeze, due to its association with childhood asthma and to aid clinicians in 
properly identifying childhood asthma as early as possible to promote positive outcomes 
and treatment responses.  
 
B. Physiology of Exposure-Outcome Relationship 
It is generally accepted that childhood asthma and persistent wheezing have roots in in-
utero and early life development, but the mechanisms behind this are not well 
understood. Since asthma is the inflammation and subsequent narrowing of the lungs’ 
airways, the proposed biological mechanism between gestational weight gain and 
childhood asthma and the persistent wheeze phenotype largely focus on two 
inflammatory and immune mechanisms: 1) leptin (Figure 1) and 2) tumor necrosis factor 
α, (TNF- α) (Figure 2). These inflammation and immune responses occur during both 
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inadequate and excessive gestational weight gain, though studies have largely focused on 
excessive gestational weight gain due to the current obesity epidemic in the United 
States.10, 20 
In terms of the first mechanism, leptin is a pro-inflammatory adipokine, a type of cell-
signaling protein known as a cytokine, that is secreted from adipose tissue.10,11 Abnormal 
cytokine production has been observed in obese individuals; high gestational weight gain 
creates an increased adiposity in the mother’s body that may cause abnormal cytokine 
production to occur. 12,13, 14, 15,39 Excessive gestational weight gain, particularly in the 
second and third trimester, has been associated with higher levels of cord blood leptin. 
16,17 It has been suggested that leptin has a pro-inflammatory effect on a child’s airways as 
it increases airway responsiveness and exacerbates asthma and asthma symptoms, such as 
wheeze.10,11,18 
In terms of the second mechanism, tumor necrosis factor α (TNF-α) is another 
cytokine that is involved with systemic inflammation.19 It has been shown that excessive 
weight gain in pregnancy relates directly to an increased capacity of infant blood cells to 
produce TNF- α, which is associated with asthma by age 9.19,20 In turn, TNF- α 
production very early in life (<3 months) is predictive of childhood asthma.19  
Childhood asthma and wheeze prevalence has been observed to differ between boys 
and girls, with boys having a higher prevalence than girls.28,29,30,40,41 This difference 
switches after puberty, where females then have a higher prevalence of asthma and 
wheeze through adulthood than males.28,29,30,40  It is suggested that the overall mechanism 
behind these sex differences is caused by differential physiologic morphology, 
maturation, and hormonal changes that occur during puberty, but these mechanisms are 
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not well understood. More specifically, some potential causes of the sex differences in 
asthma and wheeze prevalence include pulmonary dysanapsis, testosterone, hormonal 
changes’ influence on airway size, β2 adrenoceptor regulation, sex differences in the 
antioxidant response to oxidative stress, gender-influenced genetic polymorphisms and 
smooth muscle and vascular function, though it remains unclear which mechanism or 
mechanisms are the likely cause.28,29,30, 40  
 
C. Epidemiology of Exposure-Outcome Relationship 
Four epidemiologic studies have addressed the relationship between gestational 
weight gain and childhood asthma.10, 19-21 All four were prospective cohort studies. 
Two of these studies measured gestational weight gain exclusively through self-
reported post-partum questionnaire data20,21, one study used  birth certificate weight,19 
and one study used medical record extraction.10 Three of these studies measured 
childhood asthma using parent questionnaires, 10,19,21 whereas one used self-reported data 
from the child.20 Three of the studies used physician-diagnosed asthma19,20,21 and one 
used active symptoms of asthma or medicine prescribed in the past year10 as the outcome 
of interest. Each of these studies included children of different ages within their study 
population: age 4,19 ages 9-14,20 age 7,21 and ages 2-9.10 None of the studies adjusted for 
all, but some combination of, factors that have an established association between 
gestational weight gain and asthma including: family history of allergy, eczema and/or 
asthma, smoking during pregnancy, low-income status, and race/ethnicity.  Lastly, none 
of the studies have evaluated an association between trimester-specific gestational weight 
gain and offspring asthma. 
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Two studies found that low or inadequate total gestational weight gain was positively 
associated with development of childhood asthma as compared to normal or adequate 
gestational weight gain,19 though one was merely suggestive,20 whereas the other two 
studies found that high or excessive total gestational weight gain was positively 
associated with development of childhood asthma when compared to normal or adequate 
total gestational weight gain.10,22 
In the most recent prospective cohort study to date, Polinski et al. followed 6,450 
children, from birth in 2001 to age 4, in the United States.19 The authors used birth 
certificate data to obtain total gestational weight gain information, and if missing was 
obtained via self-reported values on questionnaires.19 The presence of childhood asthma 
was assessed at three time points: 9-month after birth, 2 years, and 4 years.19 At each time 
point, a parent or guardian of the child was asked during an interview whether a doctor 
had ever told them that their child has asthma.19 The authors found a 56% increased odds 
of having a child with asthma when the mother gained less than 5 kg, as compared to 
gaining 10-15 kg, after adjustment (aOR: 1.56; 95% CI: 1.04-2.35).20 This study was 
limited in that it relied upon self-reported total gestational weight gain for 19% of 
mothers who had missing birth certificate data. In addition, childhood asthma diagnosis 
in children under 4 years of age is difficult to diagnose and therefore subject to 
misclassification. Lastly, the study did not adjusted for several well-known risk factors 
such as family history of allergy, eczema and/or asthma and low-income status.   
Three epidemiologic studies have addressed the relationship between gestational 
weight gain and offspring wheezing.21, 32,39 All three were prospective cohort studies.  
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 One study measured gestational weight gain through self-reported post-partum 
questionnaire data,21 one study used the difference between self-reported pre-pregnancy 
weight and weight in the third trimester from medical records,39 and one study provided 
no information on how the gestational weight gain was measured.32 All three of these 
studies measured offspring wheeze using parental questionnaires.21, 32.39 Two of the 
studies used wheeze phenotypes, including early transient, persistent and late-onset, as 
the outcomes of interest21,32 while one study used dichotomous wheeze as the outcome.39 
Each of the three epidemiologic studies included children of different ages in their 
studies: ages 1-4 years,39 18 months to 7 years,21 and 6-7 years.32 Two of the studies 
adjusted for a number of factors that have an established association between gestational 
weight gain and offspring wheeze including family history of allergy, eczema and/or 
asthma, smoking during pregnancy, low-income status, and race/ethnicity,39,32 while one 
study did not include family history of eczema and asthma, low-income status nor 
race/ethnicity.21 None of the studies evaluated an association between trimester-specific 
gestational weight gain and offspring wheeze. 
The findings of one study was null,32 whereas one study found an increased risk of 
persistent wheeze with 5-9 kg gestational weight gain, as compared to 10-15 kg 
gestational weight gain,21 and one study found an increased risk of offspring wheeze at 1 
year and at 4 years with increasing gestational weight gain.39  
In the most recent prospective cohort study to date evaluating the relationship 
between gestational weight gain and offspring wheeze, Harpsoe et al. followed 38,874 
mothers and children from 1996 to 2002, in Denmark as part of the Danish National Birth 
Cohort.21 The authors used maternal self-reported gestational weight gain information at 
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6 months post-partum as the exposure of interest.21 Parental reported wheezing was 
obtained via telephone interview at 18 months and via questionnaire at 7 years.21 
Wheezing was categorized into early transient (>1 episode of wheezing from birth to 18 
months), persistent (both early and current wheezing), and late onset (current but not 
early wheezing).21 The authors found an increased risk of offspring persistent wheeze 
among mothers who had a gestational weight gain of  5-9 kg in comparison to mothers 
who had a gestational weight gain of 10-15 kg, after adjustment (aOR = 1.24, 95% CI: 
1.01-1.40). This study was limited for a number of reasons. First, there was a potential 
selection bias introduced since the study sample had a higher socioeconomic status than 
the source population, particularly concerning since low socioeconomic status is a risk 
factor for childhood wheezing. Second, the authors loosely used the temporal wheezing 
phenotypes based on GINA guidelines, but used wheeze assessment at 18 months as a 
proxy for the recommended 3 years. This would potentially cause misclassification of 
wheezing phenotypes since wheezing information between 18 months and 3 years would 
be lost and could change the classification of the wheeze phenotype present. Lastly, 
Harpsoe et al. lacked adjustment for some well-known risk factors for wheezing 
including family history of eczema and paternal allergy, low-income status and 
race/ethnicity.  
 Additionally, one study evaluated if sex of the child modified the association 
between gestational weight gain and offspring asthma.20 This was a prospective cohort 
study which measured gestational weight gain via maternal self-report on questionnaires 
and asthma status via child self-report on questionnaires given between age 9 years to 14 
years.20 Sex of the child did not modify the association between gestational weight gain 
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and offspring asthma.20 There have been no studies that have specifically evaluated if sex 
of the child modifies the association between gestational weight gain and offspring 
wheeze phenotypes, as wheezing is often considered as a symptom of asthma. 
 
D. Summary of Significance and Innovation 
In summary, the prior epidemiologic studies of gestational weight gain and offspring 
asthma and wheeze phenotypes have several limitations: 1) the majority relied upon self-
reported gestational weight gain, 19,20,21 2) offspring asthma was assessed among children 
of an unreliable age to be diagnosed with asthma in two of four studies, 10,19 3) offspring 
wheezing was assessed among children of an age where they would be unable to 
determine distinct phenotypes in one of three studies,39 4) well known confounders were 
inconsistently adjusted for across studies,10, 19,20,21, and 5) no prior study has evaluated the 
potential association between trimester-specific gestational weight gain and offspring 
asthma nor wheeze phenotypes. These limitations may explain the conflicting results of 
prior epidemiologic studies. Therefore, we have prospectively studied the association 
between gestational weight gain, measured at multiple time points throughout pregnancy 
via medical visits, and offspring asthma and wheeze phenotypes among children age 7 
years and 1 year to 9 years, respectively, using Project Viva cohort data. This study is 
significant because gestational weight gain is a potentially modifiable factor and if 
associated with childhood asthma and/or wheeze phenotypes, could direct new primary 
prevention efforts. This study is also significant because it evaluates whether the timing 
of gestational weight gain across trimesters is clinically relevant in the development of 
offspring asthma and/or wheeze, which could provide directed clinical recommendations 
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for prevention as well as insight into the etiology of asthma and/or wheeze phenotypes. 
This study is innovative because we have access to multiple, measured points of 
gestational weight gain via medical record abstraction, a 7 year follow-up period among 
children to more accurately diagnose asthma and a 9 year follow-up period among 
children to determine specific wheeze phenotypes, along with comprehensive information 
on potential covariates. Additionally, this study is innovative because it is the first to 
evaluate an association between trimester-specific gestational weight gain and offspring 
asthma and wheeze phenotypes. 
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CHAPTER II 
SPECIFIC AIIMS AND HYPOTHESES 
 
Specific Aim #1: To evaluate the association of gestational weight gain and offspring 
risk of asthma.  
Hypothesis #1a: There will be a U-shaped association between total gestational 
weight gain and offspring asthma. 
Hypothesis #1b: Excessive total gestational weight gain will be positively 
associated with offspring asthma, as compared to adequate total gestational 
weight gain. 
Hypothesis #2a: Second and third trimester gestational weight gain will be 
positively associated with offspring asthma. 
Hypothesis #2b: Excessive trimester-specific gestational weight gain will be 
associated with offspring asthma, as compared to adequate trimester-specific 
gestational weight gain.  
Hypothesis #3: There will be a stronger positive association between gestational 
weight gain and offspring asthma among boys, as compared to girls. 
 
Specific Aim #2: To evaluate the association of gestational weight gain and offspring 
wheezing phenotypes.  
Hypothesis #4a: There will be a U-shaped association between total gestational 
weight gain and offspring persistent wheeze. 
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Hypothesis #4b: Excessive total gestational weight gain will be positively 
associated with offspring persistent wheeze, as compared to adequate total 
gestational weight gain. 
Hypothesis #5a: Second and third trimester gestational weight gain will be 
positively associated with offspring persistent wheeze. 
Hypothesis #5b: Excessive trimester-specific gestational weight gain will be 
associated with offspring persistent wheeze, as compared to adequate trimester-
specific gestational weight gain.  
Hypothesis #6: There will be a stronger positive association between gestational 
weight gain and offspring persistent wheeze among boys, as compared to girls.  
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CHAPTER III 
STUDY DESIGN AND METHODS 
A. Overall Strategy 
We assessed the relationship between gestational weight gain and childhood 
asthma and wheeze phenotypes using data from Project Viva. Project Viva is a 
prospective cohort study based in Massachusetts, which enrolled mothers and now 
includes their singleton children.22 A total of 2341 women were recruited at their first 
prenatal visit in eastern Massachusetts between 1999 and 2002 and enrolled in the 
study.22 In-person visits were conducted with mothers during pregnancy in the late first 
(median 9.9 weeks of gestation) and second (median 27.9 weeks) trimesters.22 Mothers 
and children were later seen in the hospital during the delivery admission and then during 
infancy (median age 6.3 months), early childhood (median 3.2 years) and mid-childhood 
(median 7.7 years), with in-person visits presently continuing through the children’s 
teenage years.22  Prenatal visits occurred during pregnancy, from which medical records 
were drawn, and annual questionnaires were mailed to mothers between in-person 
visits.22 Out of the 2341 women enrolled, a total of 2128 women had a live birth and 1279 
mother-child pairs provided information at the mid-childhood visit.22  
 
B. Study Population 
Eligible participants were pregnant women less than 22 weeks gestation.22 
Women were excluded if they: 1) had a multiple gestation, 2) were unable to answer 
questions in English, 3) had a gestational age ≥ 22 weeks at recruitment, or 4) had plans 
to move away prior to delivery.22 For the purposes of this study, mothers who were 
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missing information on offspring asthma status were excluded for the analysis between 
gestational weight gain and offspring risk of asthma. As for the analysis between 
gestational weight gain and offspring risk of wheeze phenotypes, mothers who did not 
provide at least one offspring wheeze measurement from 1 year to 5 years, inclusively, 
and at least one measurement from 6 years to 9 years, inclusively, were excluded from 
the study.41 Due to the use of multiple imputation, women who had missing information 
on exposures and/or covariates were able to be included in modeling and therefore were 
not excluded from the analyses.  
 
C. Exposure Assessment 
Gestational weight gain was gathered from self-reported prepregnancy weight 
data and weight measurements from prenatal visits, ending with the last prenatal visit 
prior to birth via medical record abstraction. Trimester-specific gestational weight gain 
was interpolated from medical record weight given during prenatal visits.  
Total gestational weight gain was assessed both continuously and categorically. 
Categorical gestational weight gain was divided into three groups based on the Institute 
of Medicine (IOM) guidelines: inadequate, adequate and excessive weight gain.23 These 
guidelines recommend varying levels of weight gain for each woman dependent on their 
prepregnancy BMI.23 For women with a ‘normal’ prepregnancy BMI (18.5-24.9 kg/m2), 
weight gain should fall within 11.5-16.0 kg.23 For women with an underweight 
prepregnancy BMI (<18.5 kg/m2), weight gain should fall within 12.5-18.0 kg.23 For 
women with an overweight prepregnancy BMI (25.0-29.9 kg/m2), weight gain should fall 
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within 7.0-11.5 kg.23 For women with an obese prepregnancy BMI (≥ 30.0 kg/m2), 
weight gain should fall within 5.0-9.0 kg.23  
Trimester-specific gestational weight gain was also assessed both continuously 
and categorically, the latter based on IOM guidelines. The Institute of Medicine assumes 
a 0.5-2.0 kg weight gain in the first trimester and then varying levels of kilogram per 
week weight gain across the second and third trimesters, dependent on prepregnancy 
BMI.23 For women with a ‘normal’ prepregnancy BMI (18.5-24.9 kg/m2), mean weight 
gain per week should be 0.45 kg (range: 0.36-0.45 kg).23 For women with an underweight 
prepregnancy BMI (<18.5 kg/m2), mean weight gain per week should be 0.45 kg (range: 
0.45-0.59 kg).23 For women with an overweight prepregnancy BMI (25.0-29.9 kg/m2), 
mean weight gain per week should be 0.27 kg (range: 0.23-0.32 kg).23 For women with 
an obese prepregnancy BMI (≥ 30.0 kg/m2), mean weight gain per week should be 0.23 
kg (range: 0.18-0.27 kg).23  
Self-reported prepregnancy weight has been validated in a previous Project Viva 
study against clinically measured weights among 170 study participants who had weight 
recorded in the medical record within 3 months prior to their last menstrual period.24 The 
observed association between the self-reported and clinically measured weight was linear 
with correlation coefficients of 0.99 overall and mean underreporting of weight of 
approximately 1 kg or 2.2 pounds.24 Findings did not differ by race/ethnicity, gestational 
age at study enrollment, or weight itself.24  
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D. Outcome Assessment 
Presence of childhood asthma was assessed during the mid-childhood in-person 
visit, occurring at a median age of 7.7 years. During the in-person visit, mothers were 
asked: “Have you ever been told by a health care professional, such as a doctor, physician 
assistant or nurse practitioner, that your child has…asthma?” Mothers were additionally 
asked: “Have you ever been told by a health care professional, such as a doctor, physician 
assistant or nurse practitioner, that your child has…wheezing or reactive airways?” If the 
mother responded to either question affirmatively then she was then asked: “In the past 
12 months, has your child taken any of the following medications?” which included a 
number of medications often used for asthma, wheezing and/or reactive airways. Current 
mid-childhood asthma was considered to be present when a mother had reported that her 
child had health care professional-diagnosed asthma and had experienced wheezing or 
reactive airways and/or had taken asthma medications within the past 12 months; 
otherwise the child was considered to not have current mid-childhood asthma. Therefore, 
mid-childhood current asthma was assessed as a dichotomous outcome. 
Mother-report of health-care-professional-diagnosed childhood asthma has been 
validated in previous studies.25,26 One validation study found a high level of sensitivity 
(88.5%) and specificity (95.7%) between parental report of doctor-diagnosed asthma in 
their child and the general practitioner’s recorded diagnosis.25 A second validation study 
found a high level of agreement between parental report of offspring early onset asthma 
(<10 years of age, Cohen’s kappa 0.72) and medically-recorded diagnosis.26  
Presence of childhood wheeze was assessed during annual questionnaires from 1 
to 9 years inclusively. In each questionnaire, mothers were asked: “Since your child was 
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[age at last questionnaire], had he/she ever had wheezing (or whistling in the chest)?” 
Childhood wheeze was considered to be present when a mother had responded with a 
“Yes” to this question, otherwise the child was not considered to have wheeze at that 
time.  
After wheezing status was determined, wheeze trajectories, or phenotypes, were 
derived using latent class mixed modeling as performed by Tse et al.41 Only those 
children who had at least one wheeze measurement between 1 year and 5 years and 6 
years and 9 years, inclusively, were included in this modeling.41 Tse et al. specified 3 
latent classes, which provided the best fit.41 Three distinct wheeze phenotypes were 
identified and did not differ by sex of the child: never or infrequent wheeze, early 
transient wheeze and persistent wheeze, labeled as such based on the observed temporal 
pattern and patterns reported in the prior literature.41    
Parental report of current wheezing during early childhood has been validated in 
two studies.45, 46 Both studies found a high level of sensitivity (86%,45 82.8%46) and 
specificity (91.8%,45 85%46) between parental report of their infants’ current wheezing 
status and physician report.45, 46 Both validation studies assessed only short-term parental 
report of wheezing and included only infants.  
 
E. Covariate Assessment 
We identified established risk factors for childhood asthma based on prior 
literature.10,19,20,21 Mother’s age at enrollment, mother’s prepregnancy BMI, nulliparity, 
maternal asthma, allergy and eczema, maternal smoking during pregnancy, household 
income, maternal and paternal college graduate, maternal race/ethnicity, distance to the 
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nearest major roadway, and age in days at the mid-childhood visit were considered a 
priori confounders of the relationship between gestational weight gain and offspring 
asthma and wheeze phenotypes, respectively. Additionally, paternal asthma, allergy and 
eczema and maternal secondhand smoke exposure during pregnancy were considered risk 
factors for offspring asthma and wheeze phenotypes, respectively.  Sex of the child was 
assessed as a potential effect modifier; if it did not modify the relationship between 
gestational weight gain and offspring asthma nor wheeze phenotypes then it would be 
included as an a priori confounder. All variables were obtained from questionnaires and 
in-person visits except gestational weight gain measurements during pregnancy, which 
were obtained through medical record abstraction, and distance to the nearest roadway, 
which was calculated using distance to the nearest A1 or A2 road (U.S. Census Features 
Class) from the home address at the time of study enrollment, as performed by Rice et 
al.42 
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CHAPTER IV 
DATA ANALYSIS 
Specific Aim #1: To evaluate the association of gestational weight gain and offspring 
risk of asthma.  
Specific Aim #2: To evaluate the association of gestational weight gain and offspring 
wheezing phenotypes.  
 
A. Univariate Analysis 
The study population size after accounting for exclusion criteria, as numbers and 
percents, is presented in Table 1. We also present the mean and standard deviation of 
continuous gestational weight gain, as well as the percent distribution of categorical 
gestational weight gain in Table 2. The percent distribution of observed offspring asthma 
and wheeze phenotypes is presented in Table 3.  
 
B. Bivariate Analyses 
Covariate distributions were assessed against total and trimester-specific 
gestational weight gain, both continuously and categorically (Table 4) and against asthma 
status and wheeze phenotypes (Table 5). Continuous variables were assessed using t-tests 
and Pearson’s correlation coefficients. Categorical variables were assessed using chi-
square tests and analysis of variance (ANOVA). P-values from these tests are reported.  
Additionally, the association between total and trimester-specific gestational 
weight gain, both continuously and categorically, and current mid-childhood asthma were 
modeled using unconditional logistic regression, presented in Table 6. Odds ratios and 
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95% confidence intervals are reported. The association between total and trimester-
specific gestational weight gain, both continuously and categorically, and wheeze 
phenotypes were modeled using unconditional multinomial logistic regression, presented 
in Table 7. Adequate gestational weight gain, no current mid-childhood asthma, and 
never or infrequent wheeze served as reference. 
We explored potential non-linear relationships of continuous total gestational 
weight gain and offspring current mid-childhood asthma using generalized additive 
models (GAMs) with penalized smoothing regression splines (Figure 3), and visually 
inspected plots of the smoothed data.  
 
C. Multivariate Analyses 
Multivariable logistic regression was used to evaluate the association between 
gestational weight gain and offspring current mid-childhood asthma. Multinomial logistic 
regression was used to evaluate the association between gestational weight gain and 
offspring wheeze phenotypes. For both procedures two adjusted models were produced 
and are presented in Tables 6 and 7, respectively. In the first adjusted model, all a priori 
confounders were included due to their established association with both gestational 
weight gain and offspring asthma and wheeze phenotypes in the prior literature. In the 
second adjusted model, all a priori risk factors were included, in addition to the a priori 
confounders, due to their established association with offspring asthma and wheeze in the 
prior literature.  
Due to how common current mid-childhood asthma and wheezing are in the 
general population, we determined that the resulting odds ratios would not be a 
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reasonable approximation of the risk ratio: the statistic to be expected from a cohort 
study, such as this. Therefore, we calculated risk differences for current mid-childhood 
asthma (Table 6) and wheeze phenotypes (Table 7), respectively, using predicted 
probabilities.  
To assess whether sex of the child modified the relationship between gestational 
weight gain and offspring current mid-childhood asthma, inclusion of an interaction term 
into a multivariable logistic regression was used. The same procedure was performed in 
order to assess whether sex of the child modified the relationship between gestational 
weight gain and offspring wheeze, but through inclusion of an interaction term into a 
multivariable multinomial regression.  
To prevent potential bias associated with missing data, we imputed missing data 
on exposures and covariates using multiple imputation by chained equations. We 
specified an adequate number of iterations (n=50) according to the proportion of missing 
information.46 Mean estimates and variances were computed from the 50 imputed data 
sets using Rubin’s rule.47  
Additionally, we performed a sensitivity analysis to ascertain if the length of 
gestational age affected the estimates in comparison to the study population including all 
gestational ages. We limited the analyses to include only those who had experienced a 
full-term pregnancy, defined as having delivered the baby at 37 weeks gestation or later, 
and compared these estimates to those among the full study cohort.  
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CHAPTER V 
RESULTS 
 
Of the 2128 live births in the Project Viva cohort, we excluded 896 mother-child 
pairs that did not have information on their asthma status at mid-childhood and 833 
mother-child pairs that did not have an available wheeze trajectory (Table 1). This 
yielded an analytic cohort of 1232 mother-child pairs for the current mid-childhood 
asthma assessment and 1295 mother-child pairs for the wheeze phenotypes assessment.  
Women and their partners were predominately white, college educated and had a 
household income greater than $70,000 per year.  
Women had a mean total gestational weight gain of 15.54 kg (SD: 5.69); 13% had 
inadequate total gestational weight gain, 31% had adequate total gestational weight gain 
and 56% had excessive total gestational weight gain (Table 2). Women in their first 
trimester had a mean weight gain of 2.94 kg (SD: 2.87), in their second trimester had a 
mean weight gain of 6.31 kg (SD: 2.49) and in their third trimester had a mean weight 
gain of 6.31 kg (SD: 3.02) (Table 2). Women across all trimesters were most likely to 
have had excessive gestational weight gain, though the proportion of women having 
excessive weight gain decreases across the trimesters from 63% in the first trimester to 
57% in the third trimester (Table 2). Current mid-childhood asthma was present in 17.8% 
of children whereas 74% of children were classified as having never wheezed or had 
infrequent wheeze, 13% had early transient wheeze and 13% had persistent wheeze 
(Table 3).  
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Women who had excessive total gestational weight gain had a higher pre-
pregnancy BMI than inadequate and adequate total gestational weight gain, with women 
who had adequate weight gain having the lowest pre-pregnancy BMI (Table 4). 
Additionally, women with excessive total gestational weight gain were more likely to be 
nulliparous, be a smoker during pregnancy, have a higher income, be of other or white 
race/ethnicity, and have a boy, than women who had inadequate or adequate total 
gestational weight gain. Women who had excessive gestational weight gain during the 
first trimester were older, had a lower pre-pregnancy BMI, be a smoker during 
pregnancy, have a higher income, be a college graduate, and be of white race/ethnicity, 
than women who had inadequate or adequate first trimester gestational weight gain 
(Table 4). Women who had excessive second trimester gestational weight gain were more 
likely to be nulliparous, not have a history of asthma, be a smoker during pregnancy, 
have a higher income, be a college graduate, be of Hispanic, other or white race/ethnicity, 
and lived closer to a major roadway, than women who had inadequate or adequate second 
trimester gestational weight gain (Table 4). Women who had excessive third trimester 
gestational weight gain were younger, had a higher prepregnancy BMI, were nulliparous, 
be of other race/ethnicity, and have a boy than women who had inadequate or adequate 
gestational weight gain (Table 4).  
Children with current mid-childhood asthma were more likely to be male and to 
have younger mothers, mothers with higher pre-pregnancy BMI, maternal and paternal 
history of asthma, paternal history of allergy, a mother who smoked during the 
pregnancy, a household income less than $70,000, mothers and fathers who did not 
graduate college, mothers and fathers of African American or Hispanic race/ethnicity, 
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than children without current mid-childhood asthma (Table 5). Other covariates did not 
differ significantly among participants who did and did not have current mid-childhood 
asthma. Children with persistent wheeze were more likely to be male and to have 
younger mothers, mothers with a higher pre-pregnancy BMI, have siblings, maternal and 
paternal history of asthma, allergy and eczema, a household income less than $70,000, 
mothers and fathers who did not graduate college, mothers and fathers of African 
American or Hispanic race/ethnicity, and living closer to a major roadway than children 
with never/infrequent or early transient wheeze (Table 5). Other covariates did not differ 
significantly among participants who did and did not have persistent wheeze. 
After visual inspection of the generalized additive models, we determined there 
was a departure from linearity of total gestational weight gain and offspring current mid-
childhood asthma (Figure 3). There was no such observation among any of the three 
trimester-specific gestational weight gain and offspring current mid-childhood asthma 
(results not shown).  
We evaluated associations between total and trimester-specific gestational weight 
gain and offspring current mid-childhood asthma via logistic regression, but findings 
were not statistically significant after adjustment (Table 6). In the unadjusted analyses we 
observed an increased odds of offspring current mid-childhood asthma among children 
whose mothers had inadequate second trimester gestational weight gain (OR=2.06; 95% 
CI: 1.30-2.23), as compared to adequate second trimester gestational weight gain, though 
this was attenuated after adjustment (Table 6).  
We evaluated associations between total and trimester-specific gestational weight 
gain and offspring wheeze phenotypes via logistic regression (Table 7). We found a 36% 
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decreased odds of offspring current mid-childhood asthma among children whose mother 
had excessive third trimester gestational weight gain, as compared to adequate third 
trimester gestational weight gain (aOR: 0.64; 95% CI: 0.42-0.98) (Table 7).  
Additionally, we evaluated associations between total and trimester-specific 
gestational weight gain and offspring current mid-childhood asthma via conditional 
predicted probabilities (Table 8). We found an approximately 5% increased probability of 
having a child with current mid-childhood asthma among mothers who had inadequate 
total and inadequate second trimester gestational weight gain, respectively, as compared 
to adequate total and adequate second trimester gestational weight gain (Table 8). We 
also found an approximately 3% increased probability of having a child with current mid-
childhood asthma among mothers who had inadequate third trimester gestational weight 
gain, as compared to mothers who had adequate third trimester gestational weight gain 
(Table 8). 
Lastly, we evaluated associations between total and trimester-specific gestational 
weight gain and offspring wheeze phenotypes via conditional predicted probabilities 
(Table 9). We found an approximately 5-6% decreased probability of having a child with 
early transient wheeze among mothers who had inadequate or excessive third trimester 
gestational weight gain, as compared to mothers who had adequate third trimester 
gestational weight gain (Table 9). We also found an approximately 2-4% decreased 
probability of having a child with early transient wheeze among mothers who had 
inadequate or excessive first trimester gestational weight gain, as compared to mothers 
who had adequate first trimester gestational weight gain (Table 9). Additionally, we 
found a 2.5% increased probability of having a child with persistent wheeze among 
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mothers who had inadequate total gestational weight gain, as compared to mothers who 
had adequate total gestational weight gain (Table 9). 
We found that there is no effect modification by sex of the child in the association 
between gestational weight gain and offspring current mid-childhood asthma nor 
offspring wheeze phenotypes (results not shown). Lastly, after removing preterm 
gestational age from the overall sample in a separate analysis, findings were similar 
(results not shown).  
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CHAPTER VI 
DISCUSSION 
 
In this prospective cohort study, we found a non-linear association between total 
gestational weight gain and offspring current mid-childhood asthma. We found increased 
probabilities of offspring current mid-childhood asthma among mothers with inadequate 
second trimester, third trimester and total gestational weight gain, as compared to 
adequate gestational weight gain during those times. We also found a 36% decreased 
odds of early transient wheeze among children whose mothers had excessive gestational 
weight gain during the third trimester (aOR: 0.64; 95% CI: 0.42-0.98), as compared to 
adequate third trimester gestational weight gain. Additionally, we found a suggestive 
decreased odds of early transient wheeze among children whose mothers had inadequate 
third trimester gestational weight gain (aOR: 0.60; 95% CI: 0.36-1.02), as compared to 
adequate third trimester gestational weight gain. Lastly, we found decreased probabilities 
of offspring early transient wheeze among mothers with inadequate and excessive 
gestational weight gain during the first and third trimesters, as compared to adequate 
gestational weight gain during those times. 
Our findings for the associations between gestational weight gain and offspring 
current mid-childhood asthma are consistent with some prior literature while being 
inconsistent with others. Polinski et al. found a 56% increased odds of having a child 
with asthma when women gained less than 5 kg, as compared to women who gained 10-
15 kg (aOR: 1.56; 95% CI: 1.04-2.35). Dumas et al. found a 28% increased odds of 
childhood asthma when women had low gestational weight gain as compared to normal 
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gestational weight gain (aOR: 1.28; 95% CI: 0.98-1.66). Additionally, Harpsoe et al. 
found a 97% increased odds of current severe childhood asthma at 7 years among 
mothers who had a greater than or equal to 25 kg total gestational weight gain as 
compared to mothers who had a 10-15 kg total gestational weight gain.  Our findings 
suggest that there are increased probabilities of offspring current mid-childhood asthma 
among children whose mothers had inadequate gestational weight gain during the second 
trimester, third trimester and overall.  
Our finding of a non-linear association between total gestational weight gain and 
offspring current mid-childhood asthma is consistent with Harpsoe et al. Harpsoe et al. 
found U-shaped associations between total gestational weight gain and offspring ever 
having asthma and offspring having previous asthma. Our findings suggest a U-shaped 
association between total gestational weight gain and offspring current mid-childhood 
asthma.  
Our findings for the associations between gestational weight gain and offspring 
wheeze phenotypes are inconsistent with prior literature. Leermakers et al. found a 9% 
increased odds of wheezing from 1 to 4 years with continuous gestational weight gain, 
per standard deviation increase in weight gain (aOR: 1.09; 95% CI: 1.04-1.14). Harpsoe 
et al. found a 24% increased odds of persistent wheeze among children whose mothers 
had 5-9 kg gestational weight gain, as compared to mother with 10-15 kg gestational 
weight gain (aOR: 1.24; 95% CI: 1.01-1.40). Rusconi et al. found no association between 
wheeze phenotypes and inadequate or excessive total gestational weight gain, as 
compared to adequate total gestational weight gain. We found a 36% decreased odds of 
early transient wheeze among children whose mothers had excessive third trimester 
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gestational weight gain (aOR: 0.64; 95% CI: 0.42-0.98) and, suggestively, inadequate 
third trimester gestational weight gain (aOR: 0.60; 95% CI: 0.36-1.02), as compared to 
adequate third trimester gestational weight gain. We also found decreased probabilities of 
early transient wheeze among children whose mothers had inadequate or excessive first 
or third trimester gestational weight gain, as compared to adequate first or third trimester 
gestational weight gain.  
Differences in study findings may be due to smaller sample size in our study and 
failure of prior studies to have complete adjustment for potential confounders. Previous 
studies have oftentimes not adjusted for a number of important risk factors including, but 
not limited to: parental history of asthma, allergy and/or eczema, maternal smoking 
during pregnancy, low-income status and maternal race/ethnicity. Our study adjusted for 
all of these important risk factors and a multitude of others. Additionally, study 
populations vary widely between studies with much of the prior literature having been 
conducted outside of the United States. 
This study has several strengths. First, this was the first study to evaluate the 
relationship between gestational weight gain and offspring wheeze phenotypes, an 
informative symptomatic pattern used to clinically diagnose childhood asthma. Second, 
we measured gestational weight gain using medical records, offspring asthma at 
approximately 7 years and offspring wheeze phenotypes until 9 years. These 
measurements increase validity of both the exposure and outcome assessments since 
medically recorded weight gain is the gold standard and both asthma and wheezing 
should be measured through childhood in order to obtain the most accurate diagnoses and 
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identification. Lastly, we adjusted for all a priori confounders and risk factors based on 
prior literature and direct acyclic graphs (DAGs). 
 Total gestational weight gain was calculated by taking the difference between 
self-reported prepregnancy weight and medical record weight at the last prenatal visit 
before delivery. There is the possibility that self-reported prepregnancy weight was 
incorrectly reported. This would cause either an overestimation or underestimation of 
total gestational weight gain depending on whether women overstated or understated 
their prepregnancy weight, due to conscious misreport or rounding. If women 
misreported their prepregnancy weight this would lead to an underestimate of the true 
odds ratio (OR), though self-reported prepregnancy weight has been validated against 
clinically measured weights in a previous Project Viva study.24 It seems likely that there 
is some misclassification of total gestational weight gain due to misreporting of 
prepregnancy weight, but we expect that the impact of this misreporting is minimal since 
it has been adequately validated in this study population and was further minimized when 
evaluating gestational weight gain categorically based on the IOM guidelines.  
 Offspring current mid-childhood asthma status was determined via maternal 
report at the Mid-Childhood Visit, which occurred at a mean child age of 7.7 years. Due 
to the nature of parental reporting and the accuracy of asthma diagnoses, it is possible 
that there is misclassification of offspring asthma. This means that some mothers will 
report that a doctor had told them their child has asthma when in actuality they do not, 
and vice versa. However, validation studies on parental reporting of childhood asthma 
have found a high level of agreement between parental, particularly maternal, report of 
doctor-diagnosed asthma in their child and the general practitioner’s recorded 
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diagnosis.25,26 Additionally, we held current mid-childhood asthma to a stringent criterion 
in order to minimize the possibility of misdiagnosis by physician. Mothers needed to 
report that their child had doctor-diagnosed asthma plus had wheezing symptoms in the 
past 12 months and/or were taking asthma medications within the past 12 months. Based 
on this stringent criterion, it seems less likely that misclassification of current mid-
childhood asthma would occur. If mothers misreported their child’s asthma status or the 
child had a misdiagnosis of asthma and met the other criterion, then this would lead to an 
underestimation of the true OR.  It seems possible that there is misclassification of 
offspring asthma status but we expect that the impact is modest and will be minimized by 
the combination of validated maternal report of doctor-diagnosed offspring asthma and 
strict current mid-childhood asthma criterion. 
 Offspring wheezing was determined via maternal report on yearly questionnaires 
between ages 1 year and 9 years inclusively and then offspring wheeze phenotypes were 
derived using latent class mixed models. There is the possibility of non-differential 
misclassification of wheeze phenotypes due to the nature of parental reporting of 
symptoms and the latent class mixed models categorization procedure. This means that 
some mothers may have reported their child as having not wheezed in the past year when 
in actuality they had, or vice versa. However, validation studies on parental report of 
current wheeze symptoms have found a high agreement between parental report and 
doctor-recognized wheeze symptoms. If mothers misreported their child’s wheezing 
symptoms then this would lead to an underestimation of the true OR. It seems possible 
that there is misclassification of offspring wheeze status, which was later used to derive 
wheeze trajectories, but we expect the impact of this to be minimal since wheeze status 
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was later categorized into latent classes of wheeze trajectories and multiple wheeze 
statuses were used in these derivations, therefore misclassification would be minimized. 
Additionally, by utilizing latent classes in order to categorize wheeze phenotypes there is 
the potential for the latent class procedure to have misclassified observations into 
inaccurate wheeze phenotypes. This would have lead to an underestimation of the true 
OR. It is likely that some misclassification of wheeze phenotypes occurred during the 
latent class mixed models procedure.  
A limitation of the study was the large loss to follow-up. At the Mid-Childhood 
in-person visit, 58% (N=1232) of women from the original study sample (N=2128) 
provided information about asthma status in their child. With regard to the wheeze 
trajectories, 61% (N=1295) of women from the original study sample had provided 
sufficient information about their child’s wheezing status across 1 to 5 years and 6 to 9 
years.  
Selection bias in this study may have occurred through differential loss to follow-
up. For example, mothers who had either inadequate or excessive gestational weight gain 
and a child who was diagnosed with asthma may drop out of the study at a higher rate 
than other mother-child pairs. This specific situation could be caused by either overall 
poor health of the mother and/or child or low socioeconomic status, which could limit the 
access to resources or transportation needed to continue participation in the study, 
particularly attending the Mid-Childhood Visit where asthma assessment took place. If 
these mother-child pairs were lost from the study, this would bias the OR towards the 
null.  This scenario seems likely given the large loss to follow-up in the study, 
particularly during the in-person visits.  
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In order to limit the affect of loss to follow-up, we utilized multiple imputation. 
Through this method we were able to include mother-child pairs in the analyses who 
originally had missing information on exposures and/or covariates. These mother-child 
pairs with missing information on these factors would have otherwise been excluded 
from the analyses, if not for the use of multiple imputation. This increased our sample 
size, in comparison to a complete case analysis, and therefore increased the power of this 
study, maximizing all participant information considering our relatively small sample 
size.   
 In this prospective cohort study, information on offspring asthma was not 
collected differentially for those with different gestational weight gain. Therefore, there 
should be no information bias because asthma questions within the questionnaires and in-
person visits were a small subset of all questions asked. In addition, it would be highly 
unlikely that women would misreport their child’s asthma status differentially based on 
their gestational weight gain years prior.  
 Data on possible confounders and risk factors were gathered using numerous 
questionnaires, in-person visits and medical records. Additionally, our study had 
adequate power to include all a priori confounders and risk factors in our models. 
However, it is possible that a confounder not suggested by the literature may be missed or 
that the collection of data for the confounder left residual confounding. For example, if 
maternal dietary patterns were positively associated with gestational weight gain and 
positively associated with offspring asthma and was not controlled for in statistical 
models, the reported OR would be an overestimation of the true effect of gestational 
weight gain on offspring asthma. The impact of unmeasured confounders such as dietary 
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factors could be moderate, but thorough evaluation of prior literature for potential 
confounders and risk factors has been done and therefore it is unlikely there are major 
confounders or risk factors missing from our analyses.  
 We also accounted for the potential for residual confounding in our study by 
attempting to include multiple confounders and risk factors as proxies for a broader, or 
difficult to measure, confounder or risk factor. For example, low socioeconomic status 
has been associated with both gestational weight gain and offspring asthma and wheezing 
but this is difficult to measure. Therefore, we used a combination of parental college 
graduate status, household income, maternal race/ethnicity and others as measures of 
socioeconomic status. The impact of residual confounding could still be moderate, but 
thorough inclusion of multiple confounders and risk factors in our analyses should limit 
these effects.  
 The Project Viva cohort may have limited generalizability to other US 
populations. The cohort is largely white and college educated, with a most having a 
yearly household income over the national average in the years that information was 
collected.48 Additionally, participants resided exclusively in the greater Boston area and 
had health insurance.22  
 Additionally, here are differences in the etiology of childhood asthma and 
persistent wheezing in comparison to adult or late-onset asthma and wheezing, therefore 
these results are not generalizable to adults who develop asthma or wheezing.27 However, 
these results should be generalizable to other, diverse populations of mother-child pairs 
since the inflammatory and immune responses of leptin and tumor necrosis factor-α occur 
consistently across populations and therefore affect youth in the same way.  
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Table 1. Number and Percent in Study Sample; Project Viva 
Original Study Sample (Number of Live Births)   2128 
   
Asthma Status at Mid-Childhood   1232 (58%) 
      
Wheeze Trajectories Available   1295 (61%) 
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Table 2. Distribution of Total and Trimester-Specific Gestational Weight Gain 
among Participants with Current Mid-Childhood Asthma and with Wheeze 
Phenotypes; Project Viva 
 
 
 
 
 
 
 
 
 
 
 
N(%) M (SD) Range
Total Gestational Weight Gain (kg) 15.41 (5.37) (-7.27 - 33.18)
Total Gestational Weight Gain
Inadequate 156 (12.68%)
Adequate 395 (32.03%)
Excessive 681 (55.29%)
Trimester-Specific Gestational Weight Gain (kg)
1st Trimester 2.81 (2.76) (-8.98 - 17.96)
2nd Trimester 6.32 (2.39) (-10.55 - 14.48)
3rd Trimester 6.28 (2.90) (-10.03 - 17.55)
Trimester-Specific Gestational Weight Gain
1st Trimester - Inadequate 189 (15.39%)
1st Trimester - Adequate 269 (21.81%)
1st Trimester - Excessive 774 (62.80%)
2nd Trimester - Inadequate 146 (11.86%)
2nd Trimester - Adequate 343 (27.80%)
2nd Trimester - Excessive 743 (60.34%)
3rd Trimester - Inadequate 251 (20.40%)
3rd Trimester - Adequate 273 (22.17%)
3rd Trimester - Excessive 708 (57.43%)
Current Mid-Childhood Asthma
Table 2. Distribution of Total and Trimester-Specific Gestational Weight Gain among Participants with Current Mid-Childhood 
Asthma and with Wheeze Phenotypes; Project Viva
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Table 2 (continued). Distribution of Total and Trimester-Specific Gestational 
Weight Gain among Participants with Current Mid-Childhood Asthma and with 
Wheeze Phenotypes; Project Viva 
 
 
 
 
 
 
 
 
 
 
N(%) M (SD) Range
Total Gestational Weight Gain (kg) 15.45 (5.32) (-7.27 - 33.18)
Total Gestational Weight Gain
Inadequate 165 (12.75%)
Adequate 411 (31.76%)
Excessive 719 (55.49%)
Trimester-Specific Gestational Weight Gain (kg)
1st Trimester 2.79 (2.67) (-8.98 - 17.96)
2nd Trimester 6.38 (2.39) (-10.55 - 15.66)
3rd Trimester 6.29 (2.90) (-10.03 - 17.29)
Trimester-Specific Gestational Weight Gain
1st Trimester - Inadequate 204 (15.71%)
1st Trimester - Adequate 278 (21.49%)
1st Trimester - Excessive 813 (62.80%)
2nd Trimester - Inadequate 152 (11.71%)
2nd Trimester - Adequate 345 (26.68%)
2nd Trimester - Excessive 798 (61.61%)
3rd Trimester - Inadequate 266 (20.55%)
3rd Trimester - Adequate 286 (22.12%)
3rd Trimester - Excessive 743 (57.33%)
Wheeze Phenotypes
Table 2 (continued). Distribution of Total and Trimester-Specific Gestational Weight Gain among Participants with Current Mid-
Childhood Asthma and with Wheeze Phenotypes; Project Viva
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Table 3. Distribution of Current Asthma at Mid-Childhood and Wheeze 
Phenotypes; Project Viva 
      N   Percent     
Current Mid-Childhood Asthma (N=1232)           
No current childhood asthma     1013   82.22%     
Yes, current childhood asthma     219   17.78%     
                
Wheeze Phenotypes (N=1295)               
Never/infrequent wheeze     960   74.13%     
Early transient wheeze     165   12.74%     
Persistent wheeze     170   13.13%     
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Table 4. Distribution of Covariates According to Total and Trimester-Specific 
Gestational Weight Gain; Project Viva 
 
Table 4. Distribution of Covariates According to Total and Trimester-Specific Gestational Weight Gain; Project Viva
Continuous
Total 
Total
Inadequate
Total
Adequate
Total
Excessive
p-value N = 156 N = 395 N = 681 p-value 
Mother's Age at Enrollment; Mean (SD) -0.05 0.17 31.90 (5.74) 32.52 (5.37) 32.04 (5.04) 0.27
Mother's Pre-Pregnancy BMI; Mean (SD) -0.26 <0.0001 24.37 (6.17) 23.34 (4.71) 25.61 (5.11) <0.0001
Nulliparous; N(%)
No (N=1111) 14.70 (5.26) 168 (15.12%) 343 (30.87%) 600 (54.01%)
Yes (N=1017) 16.18 (5.38) <0.0001 115 (11.31%) 306 (30.09%) 596 (58.60%) 0.02
Maternal History of Asthma; N(%)
No (N=1842) 15.54 (5.27) 245 (13.30%) 557 (30.24%) 1040 (56.46%)
Yes (N=286) 14.49 (5.96) 0.03 38 (13.29%) 92 (32.17%) 156 (54.55%) 0.74
Paternal History of Asthma; N(%)
No (N=1884) 15.53 (5.25) 241 (12.79%) 578 (30.68%) 1065 (56.53%)
Yes (N=244) 14.54 (6.13) 0.04 42 (17.21%) 71 (29.10%) 131 (53.69%) 0.18
Maternal History of Allergy; N(%)
No (N = 1524) 15.57 (5.42) 194 (12.73%) 464 (30.45%) 866 (56.82%)
Yes (N=604) 15.02 (5.23) 0.10 89 (14.74%) 185 (30.63%) 330 (54.64%) 0.37
Paternal History of Allergy; N(%)
No (N = 1582) 15.48 (5.36) 212 (13.40%) 484 (30.59%) 886 (56.01%)
Yes (N=546) 15.22 (5.40) 0.47 71 (13.00%) 165 (30.22%) 310 (56.78%) 0.84
Maternal History of Eczema; N(%)
No (N = 1855) 15.40 (5.32) 245 (13.21%) 567 (30.57%) 1043 (56.23%)
Yes (N=273) 15.47 (5.67) 0.87 38 (13.92%) 82 (30.04%) 153 (56.04%) 0.88
Paternal History of Eczema; N(%)
No (N = 2006) 15.50 (5.32) 263 (13.11%) 613 (30.56%) 1130 (56.33%)
Yes (N = 122) 14.00 (5.84) 0.02 20 (16.39%) 36 (29.51%) 66 (54.10%) 0.53
Maternal Smoker Status during Pregnancy; N(%)
Never (N = 1457) 15.26 (5.26) 208 (14.28%) 476 (32.67%) 773 (53.05%)
Former (N = 401) 15.64 (5.21) 49 (12.22%) 111 (27.68%) 241 (60.10%)
Smoker (N = 270) 16.09 (6.38) 0.22 26 (9.63%) 62 (22.96%) 182 (67.41%) 0.0009
Maternal Secondhand Smoke Exposure; N(%)
1 hr/wk (N = 1761) 15.46 (5.27) 239 (13.57%) 538 (30.55%) 984 (55.88%)
2 hr/wk (N = 264) 15.34 (5.75) 35 (13.26%) 80 (30.30%) 149 (56.44%)
3 hr/wk (N = 51) 14.79 (6.06) 4 (7.84%) 14 (27.45%) 33 (64.71%)
4 hr/wk (N = 13) 15.52 (6.24) 0 (0.00%) 3 (23.08%) 10 (76.92%)
5 hr/wk (N = 28) 14.29 (5.93) 0.75 4 (14.29%) 11 (39.29%) 13 (46.43%) 0.46
Household	Income;	N(%)
<= $70,000 (N = 893) 15.09 (5.88) 139 (15.57%) 253 (28.33%) 501  (56.10%)
>$70,000 (N = 1235) 15.62 (5.00) 0.10 144 (11.66%) 396 (32.06%) 695 (56.28%) 0.09
Maternal	College	Graduate	Status;	N(%)
No	(N	=	754) 14.97 (6.24) 115 (15.25%) 210 (27.85%) 429 (56.90%)
Yes	(N	=	1374) 15.61 (4.92) 0.06 168 (12.23%) 439 (31.95%) 767 (55.82%) 0.23
Paternal	College	Graduate	Status;	N(%)
No	(N	=	825) 15.18 (6.16) 120 (14.55%) 213 (25.82%) 492 (59.64%)
Yes	(N	=	1303) 15.54 (4.88) 0.28 163 (12.51%) 436 (33.46%) 704 (54.03%) 0.09
Maternal	Race/Ethnicity;	N(%)
Asian	(N	=	122) 14.63 (4.15) 21 (17.21%) 51 (41.80%) 50 (40.98%)
Black	(N	=	354) 14.35 (5.92) 57 (16.10%) 110 (31.07%) 187 (52.82%)
Hispanic	(N	=	157) 14.80 (6.21) 26 (16.56%) 51 (32.48%) 80 (50.96%)
Other	(N	=	84) 16.17 (6.36) 11 (13.10%) 18 (21.43%) 55 (65.48%)
White	(N	=	1411) 15.71 (5.13) 0.0097 168 (11.91%) 419 (29.70%) 824 (58.40%) 0.002
Distance	to	Major	Roadway	at	Enrollment;	Mean	(SD) 0.03 0.15 6.69 (1.28) 6.71 (1.37) 6.84 (1.34) 0.21
Sex	of	the	Child;	N(%)
Male	(N	=	1096) 15.91 (5.30) 128 (11.68%) 329 (30.02%) 639 (58.30%)
Female	(N	=	1032) 14.92 (5.39) 0.0013 155 (15.02%) 320 (31.01%) 557 (53.97%) 0.03
Age of Child at Mid-Childhood Visit (Days); Mean (SD) -0.02 0.67 2934.16 (321.42) 2885.67 (292.82) 2885.85 (282.92) 0.16
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Table 4 (continued). Distribution of Covariates According to Total and Trimester-Specific Gestational Weight Gain; Project Viva
1st Trimester
Continuous
2nd Trimester
Continuous
3rd Trimester
Continuous
p-value p-value p-value
Mother's Age at Enrollment; Mean (SD) 0.07 0.01 -0.02 0.77 -0.15 <0.0001
Mother's Pre-Pregnancy BMI; Mean (SD) -0.6 0.26 -0.37 <0.0001 -0.13 <0.0001
Nulliparous; N(%)
No (N=1111) 2.80 (2.84) 6.09 (2.35) 5.81 (2.84)
Yes (N=1017) 2.83 (2.67) 0.86 6.56 (2.40) 0.0006 6.79 (2.87) <0.0001
Maternal History of Asthma; N(%)
No (N=1842) 2.80 (2.69) 6.41 (2.33) 6.33 (2.85)
Yes (N=286) 2.92 (3.26) 0.60 5.67 (2.64) 0.0003 5.91 (3.20) 0.10
Paternal History of Asthma; N(%)
No (N=1884) 2.86 (2.67) 6.36 (2.35) 6.32 (2.90)
Yes (N=244) 2.49 (3.35) 0.14 6.04 (2.61) 0.15 6.00 (2.87) 0.23
Maternal History of Allergy; N(%)
No (N = 1524) 2.83 (2.87) 6.39 (2.36) 6.35 (2.92)
Yes (N=604) 2.77 (2.49) 0.72 6.15 (2.44) 0.11 6.10 (2.82) 0.17
Paternal History of Allergy; N(%)
No (N = 1582) 2.94 (2.71) 6.30 (2.47) 6.24 (2.96)
Yes (N=546) 2.45 (2.88) 0.0083 6.36 (2.14) 0.70 6.41 (2.70) 0.38
Maternal History of Eczema; N(%)
No (N = 1855) 2.83 (2.77) 6.31 (2.39) 6.27 (2.88)
Yes (N=273) 2.71 (2.72) 0.64 6.41 (2.36) 0.62 6.35 (3.02) 0.75
Paternal History of Eczema; N(%)
No (N = 2006) 2.83 (2.76) 6.34 (2.34) 6.34 (2.86)
Yes (N = 122) 2.57 (2.88) 0.46 5.99 (3.00) 0.24 5.44 (3.31) 0.01
Maternal Smoker Status during Pregnancy; N(%)
Never (N = 1457) 2.75 (2.78) 6.30 (2.31) 6.21 (2.74)
Former (N = 401) 2.77 (2.45) 6.46 (2.37) 6.40 (3.19)
Smoker (N = 270) 3.35 (3.14) 0.09 6.15 (2.92) 0.48 6.59 (3.35) 0.3
Maternal Secondhand Smoke Exposure; N(%)
1 hr/wk (N = 1761) 2.78 (2.69) 6.38 (2.32) 6.30 (2.83)
2 hr/wk (N = 264) 2.96 (2.69) 6.07 (2.49) 6.32 (3.07)
3 hr/wk (N = 51) 3.02 (4.53) 6.04 (3.27) 5.73 (3.72)
4 hr/wk (N = 13) 4.25 (2.55) 5.99 (2.64) 5.28 (2.54)
5 hr/wk (N = 28) 2.22 (2.63) 0.47 5.82 (3.04) 0.41 6.25 (3.32) 0.67
Household	Income;	N(%)
<= $70,000 (N = 893) 2.95 (3.26) 6.01 (2.67) 6.12 (2.97)
>$70,000 (N = 1235) 2.72 (2.39) 0.17 6.52 (2.16) 0.0006 6.38 (2.84) 0.14
Maternal	College	Graduate	Status;	N(%)
No	(N	=	754) 2.92 (3.31) 5.97 (2.85) 6.08 (3.21)
Yes	(N	=	1374) 2.76 (2.48) 0.35 6.47 (2.14) 0.0008 6.37 (2.74) 0.10
Paternal	College	Graduate	Status;	N(%)
No	(N	=	825) 2.97 (3.35) 5.99 (2.80) 6.23 (3.12)
Yes	(N	=	1303) 2.73 (2.38) 0.17 6.50 (2.11) 0.0005 6.31 (2.77) 0.62
Maternal	Race/Ethnicity;	N(%)
Asian	(N	=	122) 2.61 (2.37) 6.33 (1.69) 5.69 (2.47)
Black	(N	=	354) 2.93 (3.71) 5.53 (2.96) 5.89 (3.19)
Hispanic	(N	=	157) 2.90 (3.04) 5.96 (2.57) 5.94 (3.11)
Other	(N	=	84) 3.47 (4.07) 6.30 (2.41) 6.40 (2.94)
White	(N	=	1411) 2.75 (2.39) 0.36 6.53 (2.23) <0.0001 6.43 (2.82) 0.05
Distance	to	Major	Roadway	at	Enrollment;	Mean	(SD) -0.05 0.22 0.05 0.02 0.04 0.05
Sex	of	the	Child;	N(%)
Male	(N	=	1096) 2.95 (2.94) 6.49 (2.41) 6.47 (2.96)
Female	(N	=	1032) 2.67 (2.56) 0.08 6.15 (2.36) 0.02 6.09 (2.81) 0.02
Age of Child at Mid-Childhood Visit (Days); Mean (SD) 0.03 0.14 -0.05 0.15 -0.04 0.32
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Table 4 (continued). Distribution of Covariates According to Total and Trimester-Specific Gestational Weight Gain; Project Viva
1st Trimester 
Inadequate
1st Trimester
Adequate
1st Trimester
Excessive
p-value
Mother's Age at Enrollment; Mean (SD) 30.39 (5.91) 31.95 (4.62) 32.69 (5.17) <0.0001
Mother's Pre-Pregnancy BMI; Mean (SD) 26.72 (6.21) 24.22 (5.02) 24.41 (4.93) <0.0001
Nulliparous; N(%)
No (N=1111) 173 (15.57%) 229 (20.61%) 709 (63.82%)
Yes (N=1017) 163 (16.03%) 207 (20.35%) 647 (63.62%) 0.89
Maternal History of Asthma; N(%)
No (N=1842) 279 (15.15%) 385 (20.91%) 1177 (63.93%)
Yes (N=286) 57 (19.86%) 51 (17.77%) 179 (62.37%) 0.13
Paternal History of Asthma; N(%)
No (N=1884) 284 (15.07%) 390 (20.70%) 1210 (64.23%)
Yes (N=244) 52 (21.31%) 46 (18.85%) 146 (59.84%) 0.05
Maternal History of Allergy; N(%)
No (N = 1524) 241 (15.81%) 325 (21.33%) 958 (62.86%)
Yes (N=604) 95 (15.73%) 111 (18.38%) 398 (65.89%) 0.32
Paternal History of Allergy; N(%)
No (N = 1582) 245 (15.50%) 322 (20.37%) 1014 (64.14%)
Yes (N=546) 92 (16.82%) 113 (20.66%) 342 (62.52%) 0.63
Maternal History of Eczema; N(%)
No (N = 1855) 292 (15.74%) 373 (20.11%) 1190 (64.15%)
Yes (N=273) 44 (16.12%) 63 (23.08%) 166 (60.81%) 0.48
Paternal History of Eczema; N(%)
No (N = 2006) 320 (15.95%) 402 (20.04%) 1284 (64.01%)
Yes (N = 122) 17 (13.93%) 34 (27.87%) 71 (58.20%) 0.31
Maternal Smoker Status during Pregnancy; N(%)
Never (N = 1457) 238 (16.32%) 318 (21.81%) 902 (61.87%)
Former (N = 401) 61 (15.21%) 80 (19.95%) 260 (64.84%)
Smoker (N = 270) 38 (14.13%) 37 (13.75%) 194 (72.12%) 0.06
Maternal Secondhand Smoke Exposure; N(%)
1 hr/wk (N = 1761) 277 (15.73%) 366 (20.78%) 1118 (63.49%)
2 hr/wk (N = 264) 44 (16.67%) 51 (19.32%) 169 (64.02%)
3 hr/wk (N = 51) 9 (17.65%) 11 (21.57%) 31 (60.78%)
4 hr/wk (N = 13) 0 (0.00%) 3 (23.08%) 10 (76.92%)
5 hr/wk (N = 28) 5 (17.86%) 3 (10.71%) 20 (71.43%) 0.67
Household	Income;	N(%)
<= $70,000 (N = 893) 180 (20.16%) 161 (18.03%) 552 (61.81%)
>$70,000 (N = 1235) 156 (12.63%) 275 (22.27%) 804 (65.10%) 0.0006
Maternal	College	Graduate	Status;	N(%)
No	(N	=	754) 155 (20.56%) 140 (18.57%) 459 (60.88%)
Yes	(N	=	1374) 181 (13.17%) 296 (21.54%) 897 (65.28%) 0.0002
Paternal	College	Graduate	Status;	N(%)
No	(N	=	825) 166 (20.10%) 154 (18.64%) 506 (61.26%)
Yes	(N	=	1303) 171 (13.13%) 282 (21.66%) 849 (65.21%) 0.0007
Maternal	Race/Ethnicity;	N(%)
Asian	(N	=	122) 21 (17.21%) 27 (22.13%) 74 (60.66%)
Black	(N	=	354) 75 (21.25%) 53 (15.01%) 225 (63.74%)
Hispanic	(N	=	157) 36 (22.93%) 33 (21.02%) 88 (56.05%)
Other	(N	=	84) 16 (19.05%) 14 (16.67%) 54 (64.29%)
White	(N	=	1411) 189 (13.39%) 308 (21.81%) 915 (64.80%) 0.004
Distance	to	Major	Roadway	at	Enrollment;	Mean	(SD) 6.76 (1.27) 6.94 (1.24) 6.73 (1.39) 0.08
Sex	of	the	Child;	N(%)
Male	(N	=	1096) 170 (15.51%) 210 (19.16%) 716 (65.33%)
Female	(N	=	1032) 167 (16.18%) 225 (21.80%) 640 (62.02%) 0.24
Age of Child at Mid-Childhood Visit (Days); Mean (SD) 2889.96 (268.80) 2878.71 (285.78) 2896.99 (298.81) 0.67
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Table 4 (continued). Distribution of Covariates According to Total and Trimester-Specific Gestational Weight Gain; Project Viva
2nd Trimester 
Inadequate
2nd Trimester
Adequate
2nd Trimester
Excessive
p-value
Mother's Age at Enrollment; Mean (SD) 31.87 (6.15) 32.52 (5.07) 32.09 (5.11) 0.33
Mother's Pre-Pregnancy BMI; Mean (SD) 26.51 (7.62) 22.96 (4.12) 25.17 (4.85) <0.0001
Nulliparous; N(%)
No (N=1111) 180 (16.20%) 296 (26.64%) 635 (57.16%)
Yes (N=1017) 100 (9.83%) 276 (27.14%) 641 (63.03%) <0.0001
Maternal History of Asthma; N(%)
No (N=1842) 225 (12.22%) 500 (27.16%) 1116 (60.62%)
Yes (N=286) 55 (19.16%) 72 (25.09%) 160 (55.75%) 0.01
Paternal History of Asthma; N(%)
No (N=1884) 250 (13.27%) 498 (26.43%) 1136 (60.30%)
Yes (N=244) 30 (12.30%) 75 (30.74%) 139 (56.97%) 0.46
Maternal History of Allergy; N(%)
No (N = 1524) 189 (12.40%) 401 (26.31%) 934 (61.29%)
Yes (N=604) 91 (15.07%) 171 (28.31%) 342 (56.62%) 0.07
Paternal History of Allergy; N(%)
No (N = 1582) 222 (14.04%) 411 (26.00%) 948 (59.962%)
Yes (N=546) 58 (10.60%) 161 (29.43%) 328 (59.96%) 0.17
Maternal History of Eczema; N(%)
No (N = 1855) 252 (13.58%) 491 (26.47%) 1112 (59.95%)
Yes (N=273) 28 (10.26%) 81 (29.67%) 164 (60.07%) 0.30
Paternal History of Eczema; N(%)
No (N = 2006) 265 (13.21%) 535 (26.67%) 1206 (60.07%)
Yes (N = 122) 14 (11.48%) 38 (31.15%) 70 (57.38%) 0.65
Maternal Smoker Status during Pregnancy; N(%)
Never (N = 1457) 202 (13.85%) 404 (27.71%) 852 (58.44%)
Former (N = 401) 37 (9.23%) 111 (27.68%) 253 (63.09%)
Smoker (N = 270) 42 (15.61%) 56 (20.82%) 171 (63.57%) 0.02
Maternal Secondhand Smoke Exposure; N(%)
1 hr/wk (N = 1761) 217 (12.32%) 483 (27.43%) 1061 (60.25%)
2 hr/wk (N = 264) 44 (16.67%) 63 (23.86%) 157 (59.47%)
3 hr/wk (N = 51) 6 (11.76%) 13 (25.49%) 32 (62.75%)
4 hr/wk (N = 13) 3 (23.08%) 2 (15.38%) 8 (61.54%)
5 hr/wk (N = 28) 7 (25.00%) 10 (35.71%) 11 (39.29%) 0.09
Household	Income;	N(%)
<= $70,000 (N = 893) 142 (15.90%) 236 (26.43%) 515 (57.67%)
>$70,000 (N = 1235) 138 (11.17%) 337 (27.29%) 760 (61.54%) 0.01
Maternal	College	Graduate	Status;	N(%)
No	(N	=	754) 130 (17.24%) 179 (23.74%) 445 (59.02%)
Yes	(N	=	1374) 150 (10.92%) 393 (28.60%) 831 (60.48%) 0.01
Paternal	College	Graduate	Status;	N(%)
No	(N	=	825) 130 (15.74%) 198 (23.97%) 498 (60.29%)
Yes	(N	=	1303) 150 (11.52%) 374 (28.73%) 778 (59.75%) 0.09
Maternal	Race/Ethnicity;	N(%)
Asian	(N	=	122) 21 (17.21%) 33 (27.05%) 68 (55.74%)
Black	(N	=	354) 76 (21.53%) 88 (24.93%) 189 (53.54%)
Hispanic	(N	=	157) 25 (15.92%) 35 (22.29%) 97 (61.78%)
Other	(N	=	84) 10 (11.90%) 19 (22.62%) 55 (65.48%)
White	(N	=	1411) 149 (10.55%) 396 (28.05%) 867 (61.40%) <0.0001
Distance	to	Major	Roadway	at	Enrollment;	Mean	(SD) 6.58 (1.50) 6.73 (1.33) 6.84 (1.31) 0.08
Sex	of	the	Child;	N(%)
Male	(N	=	1096) 131 (11.95%) 284 (27.52%) 681 (62.147%)
Female	(N	=	1032) 149 (14.44%) 288 (27.91%) 595 (57.66%) 0.06
Age of Child at Mid-Childhood Visit (Days); Mean (SD) 2919.99 (350.19) 2881.43 (277.65) 2890.27 (283.49) 0.40
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Table 4 (continued). Distribution of Covariates According to Total and Trimester-Specific Gestational Weight Gain; Project Viva
3rd Trimester
Inadequate
3rd Trimester
Adequate
3rd Trimester
Excessive
p-value
Mother's Age at Enrollment; Mean (SD) 33.00 (5.32) 32.92 (4.95) 31.60 (5.24) <0.0001
Mother's Pre-Pregnancy BMI; Mean (SD) 23.92 (5.62) 22.90 (4.28) 25.72 (5.19) <0.0001
Nulliparous; N(%)
No (N=1111) 277 (24.93%) 248 (22.32%) 586 (52.75%)
Yes (N=1017) 177 (17.40%) 223 (21.93%) 617 (60.67%) <0.0001
Maternal History of Asthma; N(%)
No (N=1842) 390 (21.18%) 414 (22.49%) 1037 (56.33%)
Yes (N=286) 64 (22.30%) 57 (19.86%) 166 (57.84%) 0.67
Paternal History of Asthma; N(%)
No (N=1884) 402 (21.34%) 412 (21.87%) 1070 (56.79%)
Yes (N=244) 52 (21.31%) 59 (24.18%) 133 (54.51%) 0.69
Maternal History of Allergy; N(%)
No (N = 1524) 311 (20.41%) 336 (22.05%) 877 (57.55%)
Yes (N=604) 143 (23.68%) 135 (22.35%) 326 (53.97%) 0.15
Paternal History of Allergy; N(%)
No (N = 1582) 362 (22.90%) 339 (21.44%) 880 (55.66%)
Yes (N=546) 92 (16.82%) 132 (24.13%) 323 (59.04%) 0.02
Maternal History of Eczema; N(%)
No (N = 1855) 398 (21.46%) 412 (22.21%) 1045 (56.33%)
Yes (N=273) 57 (20.88%) 59 (21.61%) 157 (57.51%) 0.83
Paternal History of Eczema; N(%)
No (N = 2006) 423 (21.09%) 446 (22.23%) 1137 (56.68%)
Yes (N = 122) 32 (26.23%) 24 (19.67%) 66 (54.10%) 0.40
Maternal Smoker Status during Pregnancy; N(%)
Never (N = 1457) 320 (21.95%) 336 (23.05%) 802 (55.01%)
Former (N = 401) 83 (20.70%) 84 (20.95%) 234 (58.35%)
Smoker (N = 270) 51 (18.96%) 51 (18.96%) 167 (62.08%) 0.22
Maternal Secondhand Smoke Exposure; N(%)
1 hr/wk (N = 1761) 364 (20.67%) 391 (22.20%) 1006 (57.13%)
2 hr/wk (N = 264) 57 (21.59%) 64 (24.24%) 143 (54.17%)
3 hr/wk (N = 51) 15 (29.41%) 7 (13.73%) 29 (56.86%)
4 hr/wk (N = 13) 3 (23.08%) 3 (23.08%) 7 (53.85%)
5 hr/wk (N = 28) 10 (35.71%) 5 (17.86%) 13 (46.43%) 0.26
Household	Income;	N(%)
<= $70,000 (N = 893) 201 (22.51%) 179 (20.04%) 513 (57.45%)
>$70,000 (N = 1235) 253 (20.49%) 292 (23.64%) 690 (55.87%) 0.38
Maternal	College	Graduate	Status;	N(%)
No	(N	=	754) 174 (23.08%) 150 (19.89%) 430 (57.03%)
Yes	(N	=	1374) 281 (20.45%) 321 (23.36%) 772 (56.19%) 0.30
Paternal	College	Graduate	Status;	N(%)
No	(N	=	825) 189 (22.88%) 156 (18.89%) 481 (58.23%)
Yes	(N	=	1303) 265 (20.35%) 315 (24.19%) 722 (55.45%) 0.28
Maternal	Race/Ethnicity;	N(%)
Asian	(N	=	122) 34 (27.87%) 35 (28.69%) 53 (43.44%)
Black	(N	=	354) 89 (25.21%) 67 (18.98%) 197 (55.81%)
Hispanic	(N	=	157) 38 (24.20%) 30 (19.11%) 89 (56.69%)
Other	(N	=	84) 16 (19.05%) 15 (17.86%) 53 (63.10%)
White	(N	=	1411) 276 (19.55%) 325 (23.02%) 811 (57.44%) 0.01
Distance	to	Major	Roadway	at	Enrollment;	Mean	(SD) 6.75 (1.29) 6.68 (1.42) 6.82 (1.33) 0.33
Sex	of	the	Child;	N(%)
Male	(N	=	1096) 227 (20.71%) 220 (20.07%) 649 (59.22%)
Female	(N	=	1032) 227 (22.00%) 251 (24.32%) 554 (53.68%) 0.03
Age of Child at Mid-Childhood Visit (Days); Mean (SD) 2959.80 (331.95) 2844.24 (267.98) 2886.04 (280.32) <0.0001
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Table 5. Distribution of Covariates According to Offspring Current Mid-Childhood Asthma and Wheeze Phenotype; Project Viva
No Current Mid-
Childhood Asthma
N=1013  
Current Mid-
Childhood Asthma
N=219
p-value
Mother's Age at Enrollment; Mean (SD) 32.35 (5.13) 31.36 (5.66) 0.01
Mother's Pre-Pregnancy BMI; Mean (SD) 24.47 (4.92) 25.92 (6.39) 0.001
Nulliparous; N(%)
No 514 (80.56%) 124 (19.44%)
Yes 499 (84.01%) 95 (15.99%) 0.12
Maternal History of Asthma; N(%)
No 913 (84.54%) 167 (15.46%)
Yes 100 (65.79%) 52 (34.21%) <0.0001
Paernal History of Asthma; N(%)
No 913 (84.15%) 172 (15.85%)
Yes 100 (68.03%) 47 (31.97%) <0.0001
Maternal History of Allergy; N(%)
No 731 (83.26%) 147 (16.74%)
Yes 282 (79.66%) 72 (20.34%) 0.14
Paternal History of Allergy; N(%)
No 763 (84.31%) 142 (15.69%)
Yes 250 (76.45%) 77 (23.55%) 0.003
Maternal History of Eczema; N(%)
No 887 (82.67%) 186 (17.33%)
Yes 126 (79.25%) 33 (20.75%) 0.36
Paternal History of Eczema; N(%)
No 950 (82.18%) 206 (17.82%)
Yes 63 (82.89%) 13 (17.11%) 0.80
Maternal Smoker Status during Pregnancy; N(%)
Never 714 (81.60%) 161 (18.40%)
Fomer 211 (87.92%) 29 (12.08%)
Smoker 88 (75.21%) 29 (24.79%) 0.02
Maternal Secondhand Smoke Exposure; N(%)
1 hr/wk 852 (82.88%) 176 (17.12%)
2 hr/wk 121 (79.08%) 31 (20.92%)
3 hr/wk 26 (83.87%) 5 (16.13%)
4 hr/wk 3 (60.00%) 2 (40.00%)
5 hr/wk 9 (64.29%) 5 (35.71%) 0.24
Household	Income;	N(%)
<= $70,000 368	(75.88%) 117	(24.12%)
>$70,000 645	(86.35%) 102	(13.65%) <0.0001
Maternal	College	Graduate	Status;	N(%)
No 289	(76.46%) 89	(23.54%)
Yes 724	(84.78%) 130	(15.22%) 0.0004
Paternal	College	Graduate	Status;	N(%)
No 329	(75.98%) 104	(24.02%)
Yes 684	(85.61%) 115	(14.39%) <0.0001
Maternal	Race/Ethnicity;	N(%)
Asian 55	(88.71%) 7	(11.29%)
Black 130	(68.78%) 59	(31.22%)
Hispanic 46	(60.53%) 30	(39.47%)
Other 44	(80.00%) 11	(20.00%)
White 738	(86.82%) 112	(13.18%) <0.0001
Distance	to	Major	Roadway	at	Enrollment;	Mean	(SD) 6.79	(1.33) 6.71		(1.40) 0.44
Sex	of	the	Child;	N(%)
Male 494	(79.94%) 124	(20.06%)
Female 519	(84.53%) 95	(15.47%) 0.04
Age	of	Child	at	Mid-Childhood	Visit	(Days);	Mean	(SD) 2888.58	(285.16) 2907.37	(319.11) 0.40
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Table 5 (continued). Distribution of Covariates According to Offspring Current 
Mid-Childhood Asthma and Wheeze Phenotypes; Project Viva 
 
Table 5 (continued). Distribution of Covariates According to Offspring Current Mid-Childhood Asthma and Wheeze Phenotype; Project Viva
Never/Inconsistent
Wheeze
N=960
Early Transient
Wheeze
N=165
Persistent 
Wheeze
N=170
p-value
Mother's Age at Enrollment; Mean (SD) 32.53 (5.01) 32.30 (4.77) 31.29 (5.63) 0.01
Mother's Pre-Pregnancy BMI; Mean (SD) 24.52 (5.02) 24.11 (4.84) 25.96 (6.59) 0.002
Nulliparous; N(%)
No 475 (70.90%) 93 (13.88%) 102 (15.22%)
Yes 485 (77.60%) 72 (11.52%) 68 (10.88%) 0.01
Maternal History of Asthma; N(%)
No 865 (76.62%) 129 (11.43%) 135 (11.96%)
Yes 95 (57.23%) 36 (21.69%) 35 (21.08%) <0.0001
Paernal History of Asthma; N(%)
No 865 (75.94%) 146 (12.82%) 128 (11.24%)
Yes 95 (60.90%) 19 (12.18%) 42 (26.92%) <0.0001
Maternal History of Allergy; N(%)
No 687 (76.08%) 105 (11.63%) 111 (12.29%)
Yes 273 (69.64%) 60 (15.31%) 59 (15.05%) 0.05
Paternal History of Allergy; N(%)
No 728 (76.55%) 117 (12.30%) 106 (11.15%)
Yes 232 (67.44%) 48 (13.95%) 64 (18.60%) 0.001
Maternal History of Eczema; N(%)
No 850 (75.29%) 139 (12.31%) 140 (12.40%)
Yes 110 (66.27%) 26 (15.66%) 30 (18.07%) 0.03
Paternal History of Eczema; N(%)
No 911 (74.92%) 149 (12.25%) 156 (12.83%)
Yes 49 (62.03%) 16 (20.25%) 14 (17.72%) 0.03
Maternal Smoker Status during Pregnancy; N(%)
Never 687 (75.41%) 110 (12.07%) 114 (12.51%)
Fomer 185 (70.61%) 42 (16.03%) 35 (13.34%)
Smoker 88 (72.13%) 13 (10.66%) 21 (17.21%) 0.22
Maternal Secondhand Smoke Exposure; N(%)
1 hr/wk 816 (74.52%) 138 (12.60%) 141 (12.88%)
2 hr/wk 110 (72.37%) 21 (13.82%) 21 (13.82%)
3 hr/wk 20 (71.43%) 5 (17.86%) 3 (10.71%)
4 hr/wk 5 (83.33%) 0 (0.00%) 1 (16.67%)
5 hr/wk 8	(57.14%) 2	(14.29%) 4 (28.57%) 0.53
Household	Income;	N(%)
<= $70,000 335	(68.65%) 68	(13.93%) 85	(17.42%)
>$70,000 625	(77.45%) 97	(12.02%) 85	(10.53%) 0.0007
Maternal	College	Graduate	Status;	N(%)
No 256	(68.82%) 50	(13.44%) 66	(17.74%)
Yes 704	(76.27%) 115	(12.46%) 104	(11.27%) 0.004
Paternal	College	Graduate	Status;	N(%)
No 295	(68.45%) 62	(14.39%) 74	(17.17%)
Yes 665	(76.97%) 103	(11.92%) 96	(11.11%) 0.003
Maternal	Race/Ethnicity;	N(%)
Asian 51	(78.46%) 8	(12.31%) 6	(9.23%)
Black 114	(68.67%) 16	(9.64%) 36	(21.67%)
Hispanic 44	(56.41%) 13	(16.67%) 21	(26.92%)
Other 39	(72.22%) 8	(14.81%) 7	(12.96%)
White 712	(76.39%) 120	(12.88%) 100	(10.73%) 0.001
Distance	to	Major	Roadway	at	Enrollment;	Mean	(SD) 6.79	(1.33) 6.98	(1.26) 6.59	(1.48) 0.0006
Sex	of	the	Child;	N(%)
Male 463	(69.62%) 101	(15.19%) 101	(15.19%)
Female 497	(78.89%) 64	(10.16%) 69	(10.95%) 0.0006
Age	of	Child	at	Mid-Childhood	Visit	(Days);	Mean	(SD) 2874.53	(283.77) 2881.13	(272.70) 2873.67	(292.06) 0.88
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Table 6. Unadjusted and Adjusted Odds Ratios and 95% Confidence Intervals for 
Total and Trimester-Specific Gestational Weight Gain and Offspring Current Mid-
Childhood Asthma; Project Viva 
 
 
 
 RR 95% CI RR 95% CI RR 95% CI
Total Gestational Weight Gain 0.96 0.94 - 0.99 0.98 0.95 - 1.01 0.98 0.95 - 1.01
Categorical Total Gestational Weight Gain
Inadequate vs. Adequate 1.57 1.01 - 2.46 0.64 0.40 - 1.02 0.81 0.63 - 1.03
Excessive vs. Adequate 0.88 0.63 - 1.23 1.21 0.85 - 1.73 1.09 0.91 - 1.31
Total First Trimester-Specific 
Gestational Weight Gain 1.00 0.94 - 1.05 0.98 0.93 - 1.04 0.99 0.94 - 1.05
Total Second Trimester-Specific 
Gestational Weight Gain 0.90 0.85 - 0.95 0.95 0.89 - 1.02 0.95 0.89 - 1.02
Total Third Trimester-Specific
 Gestational Weight Gain 0.95 0.90 - 1.00 0.97 0.92 - 1.02 0.97 0.91 - 1.02
Categorical First Trimester-Specific 
Gestational Weight Gain
Inadequate vs. Adequate 1.15 0.72 - 1.83 1.08 0.66 - 1.78 1.10 0.85 - 1.42
Excessive vs. Adequate 0.86 0.60 - 1.24 1.25 0.85 - 1.84 1.12 0.92 - 1.37
Categorical Second Trimester-Specific 
Gestational Weight Gain
Inadequate vs. Adequate 2.06 1.30 - 3.29 0.66 0.40 - 1.10 0.79 0.61 - 1.03
Excessive vs. Adequate 0.97 0.69 - 1.38 1.15 0.79 - 1.67 1.04 0.86 - 1.26
Categorical Third Trimester-Specific 
Gestational Weight Gain
Inadequate vs. Adequate 1.43 0.91 - 2.23 0.80 0.50 - 1.28 0.86 0.67 - 1.09
Excessive vs. Adequate 1.09 0.74 - 1.59 1.09 0.72 - 1.65 1.03 0.83 - 1.27
*Adjusted for confounders: mother's age at enrollment, mother's pre-pregnancy BMI, nulliparity, maternal asthma, maternal allergy, maternal eczema, 
maternal smoking status during pregnancy, household income above $70,000, maternal college graduate, paternal college graduate, maternal 
race/ethnicity, distance to a major roadway, sex of the child, and age in days of child at Mid-Childhood Visit
**Adjusted for confounders and risk factors: mother's age at enrollment, mother's pre-pregnancy BMI, nulliparity, maternal asthma, maternal allergy, 
maternal eczema, maternal smoking status during pregnancy, household income above $70,000, maternal college graduate, paternal college graduate, 
maternal race/ethnicity, distance to a major roadway, sex of the child, age in days of child at Mid-Childhood Visit, paternal asthma, paternal allergy, 
paternal eczema, maternal secondhand smoking status during pregnancy
Table 6. Unadjusted and Adjusted Odds Ratios and 95% Confidence Intervals for Gestational Weight Gain and Current Mid-Childhood Asthma; Project 
Viva
Current Mid-Childhood Asthma
Unadjusted Adjusted*    Adjusted**    
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Table 7. Unadjusted and Adjusted Odds Ratios and 95% Confidence Intervals for 
Total and Trimester-Specific Gestational Weight Gain and Offspring Wheeze 
Phenotypes; Project Viva 
 
OR 95% CI RR 95% CI RR 95% CI
Total Gestational Weight Gain
Early Transient Wheeze 0.99 0.96 - 1.02 0.99 0.95 - 1.02 0.99 0.95 - 1.02
Persistent Wheeze 0.96 0.93 - 0.99 0.97 0.94 - 1.01 0.98 0.95 - 1.01
Categorical Total Gestational Weight Gain
Inadequate vs. Adequate Early Transient Wheeze 1.10 0.64 - 1.92 1.16 0.65 - 2.04 1.16 0.65 - 2.06
Excessive vs. Adequate Early Transient Wheeze 1.02 0.71 - 1.48 1.06 0.72 - 1.57 1.08 0.72 - 1.60
Inadequate vs. Adequate Persistent Wheeze 1.44 0.87 - 2.38 1.35 0.80 - 2.29 1.33 0.78 - 2.29
Excessive vs. Adequate Persistent Wheeze 0.88 0.61 - 1.28 0.83 0.56 - 1.23 0.86 0.57 - 1.28
Total First Trimester-Specific
Gestational Weight Gain
Early Transient Wheeze 1.01 0.95 - 1.08 1.01 0.95 - 1.08 1.02 0.95 - 1.09
Persistent Wheeze 0.95 0.89 - 1.01 0.96 0.90 - 1.02 0.96 0.91 - 1.03
Total Second Trimester-Specific 
Gestational Weight Gain
Early Transient Wheeze 0.98 0.92 - 1.05 0.97 0.89 - 1.05 0.96 0.89 - 1.05
Persistent Wheeze 0.92 0.86 - 0.99 0.97 0.90 - 1.05 0.98 0.91 - 1.06
Total Third Trimester-Specific 
Gestational Weight Gain
Early Transient Wheeze 0.97 0.92 - 1.03 0.97 0.91 - 1.03 0.97 0.91 - 1.03
Persistent Wheeze 0.96 0.91 - 1.02 0.98 0.92 - 1.04 0.98 0.92 - 1.04
Categorical First Trimester-Specific 
Gestational Weight Gain
Inadequate vs. Adequate Early Transient Wheeze 0.72 0.41 - 1.27 0.67 0.37 - 1.20 0.66 0.37 - 1.19
Excessive vs. Adequate Early Transient Wheeze 0.80 0.54 - 1.19 0.79 0.53 - 1.20 0.80 0.53 - 1.21
Inadequate vs. Adequate Persistent Wheeze 1.14 0.68 - 1.89 0.82 0.48 - 1.41 0.78 0.44 - 1.34
Excessive vs. Adequate Persistent Wheeze 0.80 0.53 - 1.20 0.75 0.49 - 1.15 0.76 0.50 - 1.18
Categorical Second Trimester-Specific 
Gestational Weight Gain 
Inadequate vs. Adequate Early Transient Wheeze 0.89 0.48 - 1.66 0.95 0.50 - 1.80 1.00 0.52 - 1.92
Excessive vs. Adequate Early Transient Wheeze 1.02 0.69 - 1.49 1.04 0.69 - 1.54 1.06 0.71 - 1.59
Inadequate vs. Adequate Persistent Wheeze 1.73 1.01 - 2.94 1.32 0.74 - 2.36 1.39 0.77 - 2.52
Excessive vs. Adequate Persistent Wheeze 1.09 0.74 - 1.62 1.00 0.66 - 1.51 1.04 0.68 - 1.59
Categorical Third Trimester-Specific 
Gestational Weight Gain
Inadequate vs. Adequate Early Transient Wheeze 0.72 0.44 - 1.18 0.61 0.37 - 1.02 0.60 0.36 - 1.02
Excessive vs. Adequate Early Transient Wheeze 0.71 0.48 - 1.05 0.64 0.61 - 1.52 0.64 0.42 - 0.98
Inadequate vs. Adequate Persistent Wheeze 1.34 0.80 - 2.23 1.13 0.66 - 1.93 1.14 0.66 - 1.97
Excessive vs. Adequate Persistent Wheeze 1.19 0.77 - 1.83 0.96 0.61 - 1.52 0.97 0.61 - 1.55
*Adjusted for confounders: mother's age at enrollment, mother's pre-pregnancy BMI, nulliparity, maternal asthma, maternal allergy, maternal eczema,
 maternal smoking status during pregnancy, household income above $70,000, maternal college graduate, paternal college graduate, maternal race/ethnicity, paternal race/ethnicity, 
distance to a major roadway, sex of the child and age in days of child at Mid-Childhood Visit
**Adjusted for confounders and risk factors: mother's age at enrollment, mother's pre-pregnancy BMI, nulliparity, maternal asthma, maternal allergy,
 maternal eczema, maternal smoking status during pregnancy, household income above $70,000, maternal college graduate, paternal college graduate, maternal race/ethnicity, 
paternal race/ethnicity, distance to a major roadway, sex of the child, age in days of child at Mid-Childhood Visit, paternal asthma, paternal allergy, paternal eczema, maternal 
secondhand smoking status during pregnancy
Table 7. Unadjusted and Adjusted Odds Ratios and 95% Confidence Intervals for Gestational Weight Gain and Wheeze Phenotypes; Project Viva
Wheeze Phenotypes
Unadjusted Adjusted
*    
Adjusted
**    
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Table 8. Conditional Predicted Probabilities for Total and Trimester-Specific 
Gestational Weight Gain and Offspring Current Mid-Childhood Asthma; Project 
Viva 
 
 
 
Conditional 
Predicted 
Probability* 
Conditional 
Predicted 
Probability**
Table 8. Conditional Predicted Probabilities for Total and Trimester-Specific Gestational Weight Gain and Offspring
 Current Mid-Childhood Asthma; Project Viva
% %
Total Gestational Weight Gain 1 kg 17.87% 13.10%
10 kg 14.91% 11.10%
30 kg 9.78% 7.60%
Categorical Total Gestational Weight Gain
Inadequate 20.31% 15.22%
Adequate 13.95% 10.45%
Excessive 11.81% 8.93%
Total First Trimester-Specific Gestational Weight Gain 0.07 kg 13.81% 10.21%
2.94 kg 13.26% 9.97%
5.81 kg 12.72% 9.72%
Total Second Trimester-Specific Gestational Weight Gain 3.82 kg 15.04% 15.04%
6.31 kg 13.50% 13.50%
8.80 kg 12.09% 12.09%
Total Third Trimester-Specific Gestational Weight Gain 3.29 kg 14.58% 14.58%
6.31 kg 13.38% 13.38%
9.33 kg 12.28% 12.28%
Categorical First Trimester-Specific Gestational Weight Gain
Inadequate 14.15% 9.80%
Adequate 15.12% 11.60%
Excessive 12.43% 9.41%
Categorical Second Trimester-Specific Gestational Weight Gain
Inadequate 19.78% 15.26%
Adequate 14.02% 10.11%
Excessive 12.42% 9.35%
Categorical Third Trimester-Specific Gestational Weight Gain
Inadequate 16.47% 12.90%
Adequate 13.58% 9.82%
Excessive 12.58% 9.36%
*Adjusted for confounders: mother's age at enrollment, mother's pre-pregnancy BMI, nulliparity, maternal asthma, 
maternal allergy, maternal eczema, maternal smoking status during pregnancy, household income above $70,000, 
maternal college graduate, paternal college graduate, maternal race/ethnicity, paternal race/ethnicity, distance to a 
major roadway, sex of the child and age in days of child at Mid-Childhood Visit 
**Adjusted for confounders and risk factors: mother's age at enrollment, mother's pre-pregnancy BMI, nulliparity, 
maternal asthma, maternal allergy, maternal eczema, maternal smoking status during pregnancy, household income 
above $70,000, maternal college graduate, paternal college graduate, maternal race/ethnicity, paternal race/ethnicity, 
distance to a major roadway, sex of the child, age in days of child at Mid-Childhood Visit, paternal asthma, paternal 
allergy, paternal eczema, maternal secondhand smoke exposure during pregnancy
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Table 9. Conditional Predicted Probabilities for Total and Trimester-Specific 
Gestational Weight Gain and Offspring Wheeze Phenotypes; Project Viva 
 
 
 
 
 
Conditional 
Predicted 
Probability* 
Conditional 
Predicted 
Probabilities**
Table 9. Conditional Predicted Probabilities for Total and Trimester-Specific Gestational Weight Gain and 
Offspring Wheeze Phenotypes; Project Viva
% %
Total Gestational Weight Gain
Never/Infrequent 1 kg 69.73% 75.71%
10 kg 73.53% 78.35%
30 kg 80.65% 83.37%
Early Transient 1 kg 14.12% 13.25%
10 kg 13.03% 12.22%
30 kg 10.63% 10.07%
Persistent 1 kg 16.16% 11.04%
10 kg 13.45% 9.43%
30 kg 8.72% 6.56%
Categorical Total Gestational Weight Gain
Never/Infrequent Inadequate 70.88% 76.32%
Adequate 75.40% 79.98%
Excessive 76.51% 80.38%
Early Transient Inadequate 12.71% 12.12%
Adequate 11.70% 10.94%
Excessive 12.63% 11.82%
Persistent Inadequate 16.40% 11.55%
Adequate 12.90% 9.08%
Excessive 10.85% 7.80%
*Adjusted for confounders: mother's age at enrollment, mother's pre-pregnancy BMI, nulliparity, maternal 
asthma, maternal allergy, maternal eczema, maternal smoking status during pregnancy, household income 
above $70,000, maternal college graduate, paternal college graduate, maternal race/ethnicity, paternal 
race/ethnicity, distance to a major roadway, sex of the child and age in days of child at Mid-Childhood Visit 
**Adjusted for confounders and risk factors: mother's age at enrollment, mother's pre-pregnancy BMI, 
nulliparity, maternal asthma, maternal allergy, maternal eczema, maternal smoking status during pregnancy, 
household income above $70,000, maternal college graduate, paternal college graduate, maternal 
race/ethnicity, paternal race/ethnicity, distance to a major roadway, sex of the child, age in days of child at 
Mid-Childhood Visit, paternal asthma, paternal allergy, paternal eczema, maternal secondhand smoke 
exposure during pregnancy
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Table 9 (continued). Conditional Predicted Probabilities for Total and Trimester-
Specific Gestational Weight Gain and Offspring Wheeze Phenotypes; Project Viva 
 
Conditional 
Predicted 
Probability* 
Conditional 
Predicted 
Probabilities**
Table 9 (continued). Conditional Predicted Probabilities for Total and Trimester-Specific Gestational Weight 
Gain and Offspring Wheeze Phenotypes; Project Viva
% %
Total First Trimester Gestational Weight Gain
Never/Infrequent 0.07 kg 74.89% 79.64%
2.94 kg 75.83% 79.96%
5.81 kg 76.63% 80.19%
Early Transient 0.07 kg 11.93% 11.11%
2.94 kg 12.45% 11.66%
5.81 kg 12.98% 12.23%
Persistent 0.07 kg 13.18% 9.25%
2.94 kg 11.71% 8.38%
5.81 kg 10.39% 7.59%
Total Second Trimester Gestational Weight Gain
Never/Infrequent 3.82 kg 74.03% 78.51%
6.31 kg 75.51% 79.76%
8.80 kg 76.93% 80.95%
Early Transient 3.82 kg 13.26% 12.56%
6.31 kg 12.41% 11.65%
8.80 kg 11.61% 10.80%
Persistent 3.82 kg 12.71% 8.93%
6.31 kg 12.07% 8.58%
8.80 kg 11.46% 8.25%
Total Third Trimester Gestational Weight Gain
Never/Infrequent 3.29 kg 73.88% 78.43%
6.31 kg 75.56% 79.79%
9.33 kg 77.15% 81.09%
Early Transient 3.29 kg 13.49% 12.58%
6.31 kg 12.40% 11.63%
9.33 kg 11.38% 10.73%
Persistent 3.29 kg 12.63% 8.99%
6.31 kg 12.04% 8.58%
9.33 kg 11.46% 8.18%
*Adjusted for confounders: mother's age at enrollment, mother's pre-pregnancy BMI, nulliparity, maternal 
asthma, maternal allergy, maternal eczema, maternal smoking status during pregnancy, household income 
above $70,000, maternal college graduate, paternal college graduate, maternal race/ethnicity, paternal 
race/ethnicity, distance to a major roadway, sex of the child and age in days of child at Mid-Childhood Visit 
**Adjusted for confounders and risk factors: mother's age at enrollment, mother's pre-pregnancy BMI, 
nulliparity, maternal asthma, maternal allergy, maternal eczema, maternal smoking status during pregnancy, 
household income above $70,000, maternal college graduate, paternal college graduate, maternal 
race/ethnicity, paternal race/ethnicity, distance to a major roadway, sex of the child, age in days of child at 
Mid-Childhood Visit, paternal asthma, paternal allergy, paternal eczema, maternal secondhand smoke 
exposure during pregnancy
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Table 9 (continued). Conditional Predicted Probabilities for Total and Trimester-
Specific Gestational Weight Gain and Offspring Wheeze Phenotypes; Project Viva 
 
Conditional 
Predicted 
Probability* 
Conditional 
Predicted 
Probabilities**
Table 9 (continued). Conditional Predicted Probabilities for Total and Trimester-Specific Gestational Weight 
Gain and Offspring Wheeze Phenotypes; Project Viva
% %
Categorical First Trimester Gestational Weight Gain
Never/Infrequent Inadequate 74.80% 82.20%
Adequate 75.40% 76.56%
Excessive 75.94% 80.65%
Early Transient Inadequate 11.89% 9.57%
Adequate 12.23% 13.47%
Excessive 12.56% 11.31%
Persistent Inadequate 13.31% 8.22%
Adequate 12.38% 9.97%
Excessive 11.49% 8.04%
Categorical Second Trimester Gestational Weight Gain
Never/Infrequent Inadequate 74.41% 79.18%
Adequate 75.19% 79.63%
Excessive 75.84% 79.99%
Early Transient Inadequate 11.43% 10.86%
Adequate 12.04% 11.33%
Excessive 12.65% 11.81%
Persistent Inadequate 14.15% 9.96%
Adequate 12.77% 9.04%
Excessive 11.51% 8.20%
Categorical Third Trimester Gestational Weight Gain
Never/Infrequent Inadequate 75.57% 80.15%
Adequate 71.71% 75.99%
Excessive 76.63% 80.74%
Early Transient Inadequate 10.85% 10.12%
Adequate 16.84% 15.92%
Excessive 11.59% 10.91%
Persistent Inadequate 13.58% 9.73%
Adequate 11.45% 8.09%
Excessive 11.78% 8.36%
*Adjusted for confounders: mother's age at enrollment, mother's pre-pregnancy BMI, nulliparity, maternal 
asthma, maternal allergy, maternal eczema, maternal smoking status during pregnancy, household income 
above $70,000, maternal college graduate, paternal college graduate, maternal race/ethnicity, paternal 
race/ethnicity, distance to a major roadway, sex of the child and age in days of child at Mid-Childhood Visit 
**Adjusted for confounders and risk factors: mother's age at enrollment, mother's pre-pregnancy BMI, 
nulliparity, maternal asthma, maternal allergy, maternal eczema, maternal smoking status during pregnancy, 
household income above $70,000, maternal college graduate, paternal college graduate, maternal 
race/ethnicity, paternal race/ethnicity, distance to a major roadway, sex of the child, age in days of child at 
Mid-Childhood Visit, paternal asthma, paternal allergy, paternal eczema, maternal secondhand smoke 
exposure during pregnancy
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Figure 1. Physiologic Mechanisms #1: Leptin 
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Figure 2. Physiologic Mechanism #2: Tumor Necrosis Factor – α  
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Figure 3. Generalized Additive Model of Continuous Total Gestational Weight Gain 
and Offspring Current Mid-Childhood Asthma; Project Viva 
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